Processing 00000000.tx.1: Insulin Inhibits the Ubiquitin-Dependent Degrading Activity of the 26S Proteasome1 Robert G. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the Ubiquitin-Dependent Degrading Activity of the 26S Proteasome1 Robert G."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C1325411:ubiquitin activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.2: Bennett, Frederick G. 

Phrase: "Bennett,"

Phrase: "Frederick G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: Hamel and William C. 

Phrase: "Hamel"

Phrase: "and"

Phrase: "William C."
Processing 00000000.tx.4: Duckworth2 Veterans Affairs Medical Center, and the Departments of Internal Medicine and Biochemistry and Molecular Biology (R.G.B., W.C.D.) and Pharmacology (F.G.H.), University of Nebraska Medical Center, Omaha, Nebraska 68198-3020 Address all correspondence and requests for reprints to: Robert G. 

Phrase: "Duckworth2 Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1549054:Veterans Affairs [Organization]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0042610:Veterans [Population Group]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
   771 E C3245459:veteran [Intellectual Product]

Phrase: "and"

Phrase: "the Departments of Internal Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "(R.G.B.,"

Phrase: "W.C.D.)"

Phrase: "and"

Phrase: "Pharmacology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "(F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "University of Nebraska Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68198-3020"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027523:Nebraska [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Robert G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.5: Bennett, Ph.D., Research Service (151), Veterans Affairs Medical Center, 4101 Woolworth Avenue, Omaha, Nebraska 68105. 

Phrase: "Bennett,"

Phrase: "Ph.D.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1512022:Ph.D. [Intellectual Product]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Research Service"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557854:Service [Occupational Activity]
   861   C2825316:Service [Manufactured Object]
   861   C3245478:service [Idea or Concept]

Phrase: "(151"

Phrase: ")"

Phrase: ","

Phrase: "Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1549054:Veterans Affairs [Organization]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0042610:Veterans [Population Group]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   779 E C3245459:veteran [Intellectual Product]

Phrase: "4101 Woolworth Avenue,"

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68105."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]
Processing 00000000.tx.6: E-mail: rgbennet{at}unmc.edu  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  A major metabolic effect of insulin is inhibition of cellular proteolysis, but the proteolytic systems involved are unclear. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "rgbennet{at}unmc.edu  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A major metabolic effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "inhibition of cellular proteolysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C2249698:inhibition of proteolysis [Organism Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "but"

Phrase: "the proteolytic systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "are"

Phrase: "unclear."
Processing 00000000.tx.7: Tissues have multiple proteolytic systems, including the ATP- and ubiquitin-dependent proteasome pathway. 

Phrase: "Tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "have"

Phrase: "multiple proteolytic systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the ATP-"

Phrase: "and"

Phrase: "ubiquitin-dependent proteasome pathway."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   899   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   861   C1752727:Proteasome Pathway [Molecular Function]
   825 E C1523807:proteasomal pathway [Molecular Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.8: The effect of insulin on this pathway was examined in vitro and in cultured cells. 

Phrase: "The effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on this pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and in cultured cells."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C1515981:And [Idea or Concept]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.9: Insulin inhibited ATP- and ubiquitin-dependent lysozyme degradation more than 90% by reticulocyte extract, in a dose-dependent manner (IC50 50 nM). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "ATP-"

Phrase: "and"

Phrase: "ubiquitin-dependent lysozyme degradation more than 90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "by reticulocyte extract,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(IC50 50 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]
Processing 00000000.tx.10: Insulin did not reduce the conjugation of ubiquitin to lysozyme and was not itself ubiquitin-conjugated. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "the conjugation of ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1160466:conjugation [Cell Function]

Phrase: "to lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
  1000   C1416945:LYSOZYME [Gene or Genome]
  1000   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "itself ubiquitin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "conjugated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522529:Conjugated [Spatial Concept]
   966 E C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.11: In HepG2 cells, insulin increased ubiquitin-conjugate accumulation 80%. 

Phrase: "In HepG2 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "ubiquitin-conjugate accumulation 80%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.12: The association between the 26S proteasome and an intracellular protease, the insulin-degrading enzyme (IDE), was examined by a purification scheme designed to enrich for the 26S proteasome. 

Phrase: "The association between the 26S proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "an intracellular protease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "the insulin-degrading enzyme (IDE),"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "examined by a purification scheme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0243114:purification [Functional Concept]
   760   C0332128:Examined [Finding]
   760   C1519193:Scheme [Intellectual Product]
   760   C1998793:Purification [Functional Concept]

Phrase: "designed to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "enrich for the 26S proteasome."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1166804:26S proteasome [Cell Component]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0359583:Enrich [Food]
   760   C1325620:proteasome [Cell Component]
   760   C1552140:26s [Body Part, Organ, or Organ Component]
   760   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.13: Copurification of IDE activity and immunoreactivity with the proteasome were detected through several chromatographic steps. 

Phrase: "Copurification of IDE activity"

Phrase: "and"

Phrase: "immunoreactivity with the proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597879:immunoreactivity [Molecular Function]

Phrase: "were"

Phrase: "detected through several chromatographic steps."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0442726:Detected [Finding]
   760   C1261552:steps [Conceptual Entity]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726 E C1704379:Step [Functional Concept]
   726 E C1705117:Step [Quantitative Concept]
   726 E C2825408:Step [Manufactured Object]
Processing 00000000.tx.14: Glycerol gradient analysis revealed cosedimentation of IDE with the 20S proteasome and possibly with the 26S proteasome. 

Phrase: "Glycerol gradient analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "cosedimentation of IDE"

Phrase: "with the 20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "possibly with the 26S proteasome."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1166804:26S proteasome [Cell Component]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1325620:proteasome [Cell Component]
   760   C1552140:26s [Body Part, Organ, or Organ Component]
   760   C1752727:Proteasome [Molecular Function]
   760   C2362652:Possibly [Qualitative Concept]
Processing 00000000.tx.15: The proteasome-associated IDE was displaced when the samples were treated with insulin. 

Phrase: "The proteasome-associated IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "displaced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012727:Displaced [Spatial Concept]

Phrase: "when"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "treated with insulin."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.16: These results suggest that insulin regulates protein catabolism, at least in part, by decreasing ubiquitin-mediated proteasomal activity, and provides a new target for insulin action. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "protein catabolism,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0597297:protein catabolism [Molecular Function]
  1000   C1623036:protein catabolism [Molecular Function]
   861   C0543484:catabolism [Functional Concept]
   861   C0699900:Catabolism [Organism Function]
   861   C1516314:Catabolism [Physiologic Function]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by decreasing ubiquitin-mediated proteasomal activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C1325411:ubiquitin activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   804   C1622946:proteasome activity [Molecular Function]

Phrase: "and"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a new target for insulin action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.17: The displacement of IDE from the proteasome provides a mechanism for this insulin action.  

Phrase: "The displacement of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012725:Displacement [Mental Process]
   753   C0012727:Displacement [Spatial Concept]
   753   C0456080:Displacement [Qualitative Concept]
   753   C2347509:Displacement [Phenomenon or Process]

Phrase: "from the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a mechanism for this insulin action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.18: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  INSULIN PROMOTES CELLULAR growth and maintenance by a wide variety of both anabolic and anticatabolic actions, including the inhibition of overall proteolysis (1). 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "INSULIN"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "PROMOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "CELLULAR growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cellular Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "maintenance by a wide variety of both anabolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0024501:Maintenance [Activity]

Phrase: "and"

Phrase: "anticatabolic actions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441472:actions [Functional Concept]
   827 E C3266814:Action [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the inhibition of overall proteolysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C2249698:inhibition of proteolysis [Organism Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: Although insulin administration causes an increase in the synthesis of some specific proteins, the effect of insulin on the level of total cellular protein is attributable almost entirely to decreased protein degradation (2, 3). 

Phrase: "Although"

Phrase: "insulin administration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199782:insulin administration [Therapeutic or Preventive Procedure]
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the synthesis of some specific proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of total cellular protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   913   C0555903:Total protein [Laboratory Procedure]
   913   C1261360:total protein [Laboratory or Test Result]
   827   C0007634:Cellular [Cell]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178539:Cellular [Functional Concept]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   755 E C1516377:Cellularity [Qualitative Concept]

Phrase: "is"

Phrase: "attributable almost entirely to decreased protein degradation"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0597297:Protein Degradation [Molecular Function]
   778   C0597304:Protein Degradation [Molecular Function]
   778   C1623036:Protein Degradation [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0243125:degradation [Functional Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C0596130:Attributable [Mental Process]
   748   C0699900:Degradation [Organism Function]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: However, the proteolytic systems regulated by insulin are unclear. 

Phrase: "However,"

Phrase: "the proteolytic systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "regulated by insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "unclear."
Processing 00000000.tx.21: In a variety of cell types, the absence of insulin and amino acids induces formation of autophagic vacuoles and subsequent lysosomal degradation, which is reversible by the addition of insulin (2, 4, 5). 

Phrase: "In a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "the absence of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "formation of autophagic vacuoles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C2611772:autophagic vacuole formation [Cell Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "subsequent lysosomal degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "which"

Phrase: "is"

Phrase: "reversible by the addition of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205343:Reversible [Functional Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.22: Little is known about how insulin regulates proteolytic rates under more physiological conditions, such as postprandial decreases in protein degradation. 

Phrase: "Little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "about how insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "proteolytic rates under more physiological conditions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "such as postprandial decreases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0547047:decreases [Quantitative Concept]
   827 E C0392756:Decrease [Qualitative Concept]

Phrase: "in protein degradation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597297:Protein Degradation [Molecular Function]
  1000   C0597304:Protein Degradation [Molecular Function]
  1000   C1623036:Protein Degradation [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.23: Recent studies suggest that nonlysosomal mechanisms may be involved (6). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that nonlysosomal mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.24: The proteasome has been identified as the mechanism responsible for the majority of total cellular proteolysis (7). 

Phrase: "The proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "identified as the mechanism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205396:Identified [Qualitative Concept]
   770   C0441712:Mechanism [Functional Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for the majority of total cellular proteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.25: The proteasome is involved in the degradation of short- and long-lived proteins, the removal of damaged proteins, cell cycle control, transcription factor activation, and antigen presentation (8). 

Phrase: "The proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "involved in the degradation of short-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1282927:short [Qualitative Concept]
   753   C1314939:Involved [Functional Concept]
   753   C1806781:Short [Quantitative Concept]
   753   C2350002:Short [Quantitative Concept]

Phrase: "and"

Phrase: "long-lived proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the removal of damaged proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "cell cycle control,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1155872:Cell Cycle Control [Cell Function]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "transcription factor activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0162493:Transcription Activation [Genetic Function]
   827   C1879547:Activation [Activity]
   734   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "antigen presentation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0206431:Antigen Presentation [Cell Function]
   861   C0003320:Antigen [Immunologic Factor]
   861   C0449450:Presentation [Idea or Concept]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.26: Non-ATP-dependent peptide and protein degradation is carried out by the 20S proteasome, the catalytic core of all proteasome forms (9). 

Phrase: "Non-ATP-dependent peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "protein degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597297:Protein Degradation [Molecular Function]
  1000   C0597304:Protein Degradation [Molecular Function]
  1000   C1623036:Protein Degradation [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by the 20S proteasome,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
   806   C1166808:20S proteasome [Cell Component]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1325620:proteasome [Cell Component]
   760   C1552134:20s [Body Part, Organ, or Organ Component]
   760   C1752727:Proteasome [Molecular Function]

Phrase: "the catalytic core of all proteasome forms"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0600499:Catalytic Core [Amino Acid Sequence]
   748   C0444669:Core [Spatial Concept]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.27: The major nonlysosomal ATP-dependent proteolytic pathway is the ubiquitin system (10), involving the 26S proteasome, consisting of the 20S enzyme and regulatory subunits. 

Phrase: "The major nonlysosomal ATP-dependent proteolytic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1704259:Pathway [Molecular Function]
   799   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "the ubiquitin system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the 26S proteasome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "consisting of the 20S enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C1552134:20s [Body Part, Organ, or Organ Component]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "regulatory subunits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.28: The ubiquitin pathway requires both ATP and conjugation of a small polypeptide, ubiquitin (Ub), to lysine residues of target substrates (11, 12). 

Phrase: "The ubiquitin pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "requires"

Phrase: "both ATP"

Phrase: "and"

Phrase: "conjugation of a small polypeptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1160466:conjugation [Cell Function]

Phrase: "ubiquitin (Ub),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to lysine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "of target substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.29: This ligation of ubiquitin by a series of ubiquitin-conjugating enzymes is repeated, to produce polyubiquitin chains, which serve as targeting signals for degradation of the protein by the 26S proteasome. 

Phrase: "This ligation of ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023690:Ligation [Therapeutic or Preventive Procedure]

Phrase: "by a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of ubiquitin-conjugating enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0084913:Ubiquitin-Conjugating Enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0301869:Conjugate [Immunologic Factor]

Phrase: "is"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "polyubiquitin chains,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: "which"

Phrase: "serve as targeting signals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1521840:Targeting [Functional Concept]
   737   C1710082:Signal [Phenomenon or Process]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "for degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by the 26S proteasome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.30: The importance of the ubiquitin-proteasome pathway of protein degradation is becoming increasingly apparent as more endogenous protein substrates are identified and regulation of the pathway in a number of pathophysiological states, including starvation and sepsis, is observed (13, 14). 

Phrase: "The importance of the ubiquitin-proteasome pathway of protein degradation"

Phrase: "is"

Phrase: "becoming"

Phrase: "increasingly apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750489:apparent [Idea or Concept]

Phrase: "as"

Phrase: "more endogenous protein substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "regulation of the pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "in a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of pathophysiological states,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "starvation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038187:Starvation [Finding]

Phrase: "and"

Phrase: "sepsis,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0036690:Sepsis [Disease or Syndrome]
  1000   C0243026:Sepsis [Disease or Syndrome]
  1000   C1090821:Sepsis [Eukaryote]
   928 E C0333534:Septic [Functional Concept]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.31: In muscle from diabetic rats, insulin reversed increased ATP-dependent proteolysis (15), but the effect of insulin on the ubiquitin pathway of ATP-dependent proteolysis is, as yet, unclear. 

Phrase: "In muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "from diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "increased ATP-dependent proteolysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C1157967:ATP-dependent proteolysis [Molecular Function]
   812   C0597304:Proteolysis [Molecular Function]
   741 E C1947941:proteolytic [Enzyme]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the ubiquitin pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "of ATP-dependent proteolysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1157967:ATP-dependent proteolysis [Molecular Function]
   827   C0597304:Proteolysis [Molecular Function]
   755 E C1947941:proteolytic [Enzyme]

Phrase: "is"

Phrase: ","

Phrase: "as yet,"

Phrase: "unclear."
Processing 00000000.tx.32: Previously, we showed that insulin inhibits ATP-independent peptide-degrading activity by the proteasome in vitro (16, 17) and in cultured cells (18). 

Phrase: "Previously,"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ATP-independent peptide-degrading activity by the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1622946:proteasome activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")"

Phrase: "and in cultured cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C1515981:And [Idea or Concept]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.33: The ability of insulin to inhibit this proteasome activity was mediated by a copurifying protein, the insulin-degrading enzyme (IDE) (19, 20, 21). 

Phrase: "The ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "this proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "mediated by a copurifying protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "the insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "(19,"

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.34: The IDE is a primarily cytosolic enzyme that is the initial member of a family of zinc metalloproteinases (22), and it is responsible for the degradation of insulin in most tissues (23, 24). 

Phrase: "The IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a primarily cytosolic enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "the initial member of a family of zinc metalloproteinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "responsible for the degradation of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "in most tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.35: In the present study, we found that insulin inhibited ATP- and ubiquitin-dependent proteolysis in an in vitro extract, and that insulin increased the accumulation of ubiquitin-conjugated proteins in cultured hepatoma cells. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "ATP-"

Phrase: "and"

Phrase: "ubiquitin-dependent proteolysis in an in vitro extract,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C1157991:ubiquitin-dependent proteolysis [Molecular Function]
   744   C0597304:Proteolysis [Molecular Function]

Phrase: "and"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the accumulation of ubiquitin-conjugated proteins"

Phrase: "in cultured hepatoma cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   867   C0677626:hepatoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C2239176:Hepatoma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.36: Furthermore, we observed copurification of IDE through several steps of a skeletal muscle 26S proteasome purification series. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "copurification of IDE"

Phrase: "through several steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "of a skeletal muscle 26S proteasome purification series."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C0202616:Skeletal series [Diagnostic Procedure]
   799   C0205549:Series [Quantitative Concept]
   799   C2348044:Series [Intellectual Product]
Processing 00000000.tx.37: Insulin treatment resulted in dissociation of IDE from the proteasome. 

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in dissociation of IDE"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "from the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.38: These data support involvement of IDE in the regulation of proteasome activity by insulin.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "involvement of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.39: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Human crystalline insulin and 125I-insulin were generously provided by Ronald Chance and Bruce Frank, respectively (Lilly Research Laboratories, Indianapolis, IN). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Human crystalline insulin"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   913   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0444626:Crystalline [Chemical Viewed Structurally]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "generously"

Phrase: "provided by Ronald Chance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237506:Chance [Qualitative Concept]
   770   C1999230:Provided [Activity]

Phrase: "and"

Phrase: "Bruce Frank,"

Phrase: "respectively"

Phrase: "(Lilly Research Laboratories,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   867   C0022886:research laboratory [Research Activity]
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.40: The C59 antibody specific for ubiquitin was provided by Terrence Donohue (Omaha Veterans Affairs Medical Center) The IDE-specific monoclonal antibody 9B12 was provided by Richard Roth (Stanford University, Stanford, CA) (25). 

Phrase: "The C59"

Phrase: "antibody specific for ubiquitin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   819   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
   761 E C0003264:Antibody Specificity [Molecular Function]

Phrase: "was"

Phrase: "provided by Terrence Donohue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: "(Omaha Veterans Affairs Medical Center"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1549054:Veterans Affairs [Organization]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0042610:Veterans [Population Group]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
   771 E C3245459:veteran [Intellectual Product]

Phrase: ")"

Phrase: "The IDE-specific monoclonal antibody 9B12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C0021644:Insulin antibody [Immunologic Factor]

Phrase: "was"

Phrase: "provided by Richard Roth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: "(Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA) (25"

Phrase: ")."
Processing 00000000.tx.41: The polyclonal antiserum against the 20S proteasome was provided by Walter Ward (University of Texas Health Science Center, San Antonio, TX) (26). 

Phrase: "The polyclonal antiserum against the 20S proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "provided by Walter Ward"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1305702:Ward [Health Care Related Organization,Manufactured Object]
   770   C1547134:Ward [Idea or Concept]
   770   C1999230:Provided [Activity]
   770   C2355574:Ward [Population Group]

Phrase: "(University of Texas Health Science Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   799   C0018684:Health [Idea or Concept]
   799   C0036397:Science [Occupation or Discipline]
   799   C0039711:Texas [Geographic Area]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]

Phrase: "San Antonio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "TX) (26"

Phrase: ")."
Processing 00000000.tx.42: Curve-fitting and statistical analyses were performed using GraphPad Prism version 3.00 (GraphPad Software, Inc., San Diego, CA). 

Phrase: "Curve-fitting"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0036572:Fitting [Sign or Symptom]
   861   C0205134:Curve [Spatial Concept]
   861   C0441548:Fitting [Health Care Activity]
   827 E C0424576:Fit [Finding]
   827 E C2349186:Fit [Activity]

Phrase: "and"

Phrase: "statistical analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GraphPad Prism version 3.00"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0333052:Version [Functional Concept]
   804   C0814195:PRISM [Intellectual Product]
   804   C2607870:Version [Spatial Concept]
   748 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(GraphPad Software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "Inc.,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.43: Ub-conjugation and Ub-dependent degradation of lysozyme Rabbit reticulocyte lysate (Green Hectares, Oregon, WI) was fractionated to produce Fraction II, as described (27). 

Phrase: "Ub-conjugation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1160466:conjugation [Cell Function]
   789 E C0522529:Conjugated [Spatial Concept]

Phrase: "and"

Phrase: "Ub-dependent degradation of lysozyme Rabbit reticulocyte lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "(Green Hectares,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348947:Hectare [Quantitative Concept]

Phrase: "Oregon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029195:Oregon [Geographic Area]

Phrase: "WI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "was"

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "Fraction II,"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.44: Lysozyme and ubiquitin were iodinated by the chloramine-T method (28). 

Phrase: "Lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
  1000   C1416945:LYSOZYME [Gene or Genome]
  1000   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "iodinated by the chloramine-T method"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0055332:Chloramin T [Organic Chemical,Pharmacologic Substance]
   753   C0008164:Chloramine [Organic Chemical]
   753   C0025033:Chloramin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0025663:Method [Intellectual Product]
   753   C0055330:chloramine [Inorganic Chemical]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.45: Ub-dependent degradation of 125I-lysozyme by Fraction II (50 g total protein) was measured by trichloroacetic acid solubility ,as described (29), except that dithiothreitol was limited to that present in the enzyme, to minimize disulfide reduction of insulin. 

Phrase: "Ub-dependent degradation of 125I-lysozyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "by Fraction II"

Phrase: "(50 g total protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0555903:Total protein [Laboratory Procedure]
   861   C1261360:total protein [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439175:% total [Quantitative Concept]
   812   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "measured by trichloroacetic acid solubility ,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0037628:Solubility [Qualitative Concept]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "limited to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0439801:Limited [Functional Concept]
   833   C3542948:Limited [Intellectual Product]
   799 E C1549649:Limit [Idea or Concept]
   799 E C2349209:Limit [Conceptual Entity]

Phrase: "that present in the enzyme,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "disulfide reduction of insulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2267001:Disulfide Reduction [Molecular Function]
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.46: The reaction included either ATP-regenerating (22) or ATP-depleting (60 U/ml hexokinase, 10 mM 2-deoxyglucose) systems, and the rate of ATP-dependent degradation was taken as the difference. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "either ATP-"

Phrase: "regenerating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0334213:regenerating [Functional Concept]

Phrase: "(22"

Phrase: ")"

Phrase: "or"

Phrase: "ATP-"

Phrase: "depleting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   928   C1550032:Unload [Idea or Concept]
   928   C1880497:Empty [Qualitative Concept]
   928   C1996907:Emptying [Activity]
   907 E C0333668:Depleted [Functional Concept]

Phrase: "(60 U/ml hexokinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019472:HEXOKINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0523692:Hexokinase [Laboratory Procedure]

Phrase: "10 mM 2-deoxyglucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0011501:Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0449913:System [Functional Concept]
   966   C1553451:System [Manufactured Object]
   966   C1704459:System [Medical Device]
   916 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "the rate of ATP-dependent degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "taken as the difference."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.47: The total time of incubation was 3 h at 37 C, which typically resulted in approximately 10% trichloroacetic acid solubility in the presence of both ATP and ubiquitin, with approximately 1% solubility in the absence of ATP and/or ubiquitin. 

Phrase: "The total time of incubation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "was"

Phrase: "3 h at 37 C,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041119:3 H [Element, Ion, or Isotope]
   797   C3540507:H-37 [Gene or Genome]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "which typically"

Phrase: "resulted in approximately 10% trichloroacetic acid solubility"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0037628:Solubility [Qualitative Concept]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0332232:Approximately [Qualitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of both ATP"

Phrase: "and"

Phrase: "ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with approximately 1% solubility"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0037628:Solubility [Qualitative Concept]
   755 E C1749467:soluble [Cell Component]
   755 E C1948047:Soluble [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of ATP"

Phrase: "and/or"

Phrase: "ubiquitin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.48: Some experiments were performed with the addition of 50 g/ml of the inhibitory monoclonal anti-IDE antibody C203.1A (17, 19). 

Phrase: "Some experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed with the addition of 50 g/ml"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C1300565:g/mL [Quantitative Concept]
   767 E C1637390:mL/g [Quantitative Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C0884358:Performed [Functional Concept]
   744   C1883712:Addition [Functional Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "of the inhibitory monoclonal anti-IDE antibody C203.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0450344:1A [Intellectual Product]
   791   C1553633:1a [Medical Device]

Phrase: "(17,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.49: Unlabeled lysozyme was conjugated to 125I-ubiquitin using Fraction II with hemin to prevent breakdown of the ubiquitin-lysozyme conjugates (22). 

Phrase: "Unlabeled lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
   861   C1416945:LYSOZYME [Gene or Genome]
   861   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "was"

Phrase: "conjugated to 125I-ubiquitin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0522529:Conjugated [Spatial Concept]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fraction II with hemin to"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "breakdown of the ubiquitin-lysozyme conjugates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0443161:break down [Qualitative Concept]
   753   C0699900:breakdown [Organism Function]
   753   C1265875:breakdown [Acquired Abnormality]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.50: Insulin-ubiquitin conjugation was assessed as above, except that 125I-labeled insulin was used instead of 125I-ubiquitin, with 1 mg/ml bacitracin to reduce the amount of insulin degradation. 

Phrase: "Insulin-ubiquitin conjugation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1160466:conjugation [Cell Function]
   755 E C0522529:Conjugated [Spatial Concept]

Phrase: "was"

Phrase: "assessed as above,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516048:Assessed [Activity]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that 125I-labeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "used instead of 125I-ubiquitin,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C1524063:Use of [Functional Concept]
   760   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "with 1 mg/ml bacitracin to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "reduce"

Phrase: "the amount of insulin degradation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.51: The levels of 125I-ubiquitin-protein conjugation were analyzed by SDS-PAGE and PhosphorImager analysis (Molecular Dynamics, Inc., Sunnyvale, CA). 

Phrase: "The levels of 125I-ubiquitin-protein conjugation"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   833   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   790   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   783   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0038720:Sulfate [Inorganic Chemical]
   753   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0936012:Analyzed [Research Activity]
   753   C1704732:Page [Intellectual Product]
   753   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "PhosphorImager analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(Molecular Dynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: "Inc.,"

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.52: Immunodetection of ubiquitin-protein conjugates from HepG2 cell lysates Subconfluent cultures of human hepatoma (HepG2) cells (American Type Culture Collection, Rockville, MD) were maintained in DMEM with 10% FBS, then changed to serum-free DMEM for 16 h before treatment with insulin for 2 h. 

Phrase: "Immunodetection of ubiquitin-protein"

Phrase: "conjugates from HepG2 cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C2717940:HepG2 Cell [Cell]
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C0301869:Conjugate [Immunologic Factor]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "Subconfluent"

Phrase: "cultures of human hepatoma"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0010453:Culture [Idea or Concept]
   770   C0023903:Hepatoma [Neoplastic Process]
   770   C0086418:Human [Human]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C2239176:Hepatoma [Neoplastic Process]
   770   C2242979:Culture [Laboratory Procedure]

Phrase: "(HepG2"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(American Type Culture Collection,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0598079:American Type Culture Collection [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0596070:American [Population Group]
   812   C1516698:Collection [Functional Concept]
   812   C1547052:*Type [Quantitative Concept]
   812   C1704814:Collection [Idea or Concept]
   812   C2242979:Culture [Laboratory Procedure]
   741 E C1516695:Collected [Idea or Concept]

Phrase: "Rockville,"

Phrase: "MD)"

Phrase: "were"

Phrase: "maintained in DMEM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "with 10% FBS,"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "changed to serum-free DMEM"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C0392747:Changed [Functional Concept]
   760   C0443172:Changed [Quantitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.53: Cells were washed with ice-cold PBS, then scraped into lysis buffer (50 mM Tris (pH 7.4), containing 1% Triton X-100; 150 mM NaCl; 5 mM EDTA; 5 mM N-ethylmaleimide; 1 mM Na3VO4; 40 mM NaF; 1 mM phenylmethyl sulfonyl fluoride; 10 g/ml each leupeptin, aprotinin, and soybean trypsin inhibitor; 10 M pepstatin-A; 10 M dichloroisocoumarin; and 10 M hemin). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with ice-cold PBS,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1548982:Washed [Idea or Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726 E C0441648:Wash [Activity]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "scraped into lysis buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C0184933:scraped [Therapeutic or Preventive Procedure]
   770   C0444082:scraped [Body Substance]
   770   C1536403:lysis [Cell Function]

Phrase: "(50 mM Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "; 150 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "; 5 mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "; 5 mM N-ethylmaleimide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "; 1 mM Na3VO4"

Phrase: "; 40 mM NaF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "; 1 mM phenylmethyl sulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0075613:sulfonyl fluoride [Hazardous or Poisonous Substance,Inorganic Chemical]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "; 10 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "each leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "soybean trypsin inhibitor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0041242:trypsin inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0037733:Soy bean [Food]
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0947608:SOYBEAN [Pharmacologic Substance]
   827   C1262902:Soybean [Plant]
   827   C1999216:Inhibitor [Qualitative Concept]
   827   C3257531:soybean [Pharmacologic Substance]

Phrase: "; 10 M pepstatin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A"

Phrase: "; 10 M dichloroisocoumarin"

Phrase: ";"

Phrase: "and"

Phrase: "10 M hemin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018988:Haemin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.54: After one freeze-thaw cycle, the samples were centrifuged at 10,000 x g for 10 min, and the supernatants were assayed for protein content by bicinchoninic acid assay (Pierce Chemical Co., Rockford, IL). 

Phrase: "After one freeze-thaw cycle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511572:Cycle [Temporal Concept]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged at 10,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "assayed for protein content"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "by bicinchoninic acid assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0053554:bicinchoninic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Pierce Chemical Co.,"

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.55: Samples were resolved on 12% SDS-PAGE, transferred to Immobilon-P (Millipore Corp., Bedford, MA), then probed with C59 antibody specific for ubiquitin (30), and visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech, Piscataway, NJ). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "resolved on 12% SDS-PAGE,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   814   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   778   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   774   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C1704732:Page [Intellectual Product]
   748   C2699488:Resolved [Conceptual Entity]
   748   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "transferred to Immobilon-P (Millipore Corp.,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0123400:Immobilon P [Organic Chemical]
   753   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   753   C0348011:transferred [Functional Concept]
   753   C0683758:Corp. [Organization]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")"

Phrase: ","

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed with C59"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "antibody specific for ubiquitin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   819   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
   761 E C0003264:Antibody Specificity [Molecular Function]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "visualized by enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.56: Loading controls were performed by reprobing with anti -tubulin monoclonal antibody (Sigma, St. Louis, MO) and alkaline phosphatase detection. 

Phrase: "Loading controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "performed by reprobing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with anti -tubulin monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St. Louis,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "and"

Phrase: "alkaline phosphatase detection."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511790:Detection [Therapeutic or Preventive Procedure]
   734   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.57: Immunoreactive proteins, were quantitated by densitometry. 

Phrase: "Immunoreactive proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "quantitated by densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.58: Purification of 26S proteasome from rat skeletal muscle The 26S proteasome was prepared from rat skeletal muscle by DEAE-Sephacel chromatography, polyethylene glycol precipitation, phosphocellulose chromatography, and centrifugation at 100,00 x g, as described earlier (31) but with the omission of dithiothreitol and EDTA from the buffers to preserve IDE-proteasome interaction. 

Phrase: "Purification of 26S proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243114:purification [Functional Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "from rat skeletal muscle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "The 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "was"

Phrase: "prepared from rat skeletal muscle"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   806   C0242692:Muscle, Skeletal [Tissue]
   806   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   760   C0026845:Muscle [Tissue]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0037253:skeletal [Body System]
   760   C0521324:Skeletal [Spatial Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "by DEAE-Sephacel chromatography,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0598730:DEAE chromatography [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   727 E C0302647:chromatograph [Medical Device]

Phrase: "polyethylene glycol precipitation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0444679:Polyethylene glycol precipitation [Laboratory Procedure]
   827   C0032931:Precipitation [Natural Phenomenon or Process]
   827   C0032932:Precipitation [Molecular Function]
   827   C1642401:% precipitation [Quantitative Concept]
   827   C2584299:Precipitation [Natural Phenomenon or Process]
   734   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "phosphocellulose chromatography,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0008550:Chromatography [Laboratory Procedure]
   761 E C0302647:chromatograph [Medical Device]

Phrase: "and"

Phrase: "centrifugation at 100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "00 x g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "but with the omission of dithiothreitol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   753   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "EDTA from the buffers to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "preserve"

Phrase: "IDE-proteasome interaction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C3537101:Enzyme Interaction [Molecular Function]
   840   C1514525:Proteasome Interaction [Molecular Function]
   804   C1704675:Interaction [Functional Concept]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
Processing 00000000.tx.59: Further analysis was performed on 1040% linear glycerol gradients in 50 mM Tris (pH 7.5), containing 0.1 mM ATP (30 ml total). 

Phrase: "Further analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed on 1040% linear glycerol gradients"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   753   C0205132:Linear [Spatial Concept]
   753   C0812409:gradients [Quantitative Concept]
   753   C0884358:Performed [Functional Concept]
   719 E C0439182:% gradient [Quantitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in 50 mM Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1 mM ATP"

Phrase: "(30 ml total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.60: The gradients were centrifuged at 100,000 x g for 16 h, then fractions (0.9 ml) were collected from the bottom. 

Phrase: "The gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0812409:gradients [Quantitative Concept]
   966 E C0439182:% gradient [Quantitative Concept]

Phrase: "were"

Phrase: "centrifuged at 100,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 16 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "then fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "(0.9 ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "collected from the bottom."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1511276:Bottom [Spatial Concept]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1552825:bottom [Idea or Concept]
Processing 00000000.tx.61: Aliquots of each fraction were assayed for insulin-degrading activity and for succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin (LLVY)-degrading activity, with and without 0.02% SDS (17). 

Phrase: "Aliquots of each fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "assayed for insulin-degrading activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "for succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin"

Phrase: "(LLVY"

Phrase: ")-"

Phrase: "degrading activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "with"

Phrase: "and without 0.02% SDS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   778   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   774   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1515981:And [Idea or Concept]
   748   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.62: Samples were analyzed for IDE or the proteasome by Western blotting and detection by enhanced chemiluminescence.  

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed for IDE"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0936012:Analyzed [Research Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "the proteasome by Western blotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1325620:proteasome [Cell Component]
   760   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "detection by enhanced chemiluminescence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.63: Results Top Abstract Introduction Materials and Methods Results Discussion References  Because insulin was previously shown to inhibit the ATP-independent activity of the proteasome, we sought to determine the effect of insulin on ATP- and ubiquitin-dependent proteolysis. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Because"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the ATP-independent activity of the proteasome,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1622946:proteasome activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on ATP-"

Phrase: "and"

Phrase: "ubiquitin-dependent proteolysis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1157991:ubiquitin-dependent proteolysis [Molecular Function]
   827   C0597304:Proteolysis [Molecular Function]
   755 E C1947941:proteolytic [Enzyme]
Processing 00000000.tx.64: A partially purified preparation from ATP-depleted rabbit reticulocyte lysate, known as Fraction II (27), is largely devoid of endogenous ATP and ubiquitin but contains the necessary factors for both the formation and degradation of ubiquitin-protein conjugates. 

Phrase: "A partially purified preparation from ATP-depleted rabbit reticulocyte lysate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0455052:Preparation [Health Care Activity]
   739   C1521827:Preparation [Functional Concept]

Phrase: "known as Fraction II"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205309:Known [Qualitative Concept]
   770   C1264633:Fraction [Quantitative Concept]
   770   C1554103:Fraction [Idea or Concept]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "largely devoid of endogenous ATP"

Phrase: "and"

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the necessary factors for both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "degradation of ubiquitin-protein conjugates."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0597297:Protein Degradation [Molecular Function]
   797   C0597304:Protein Degradation [Molecular Function]
   797   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.65: The effect of insulin on ATP-dependent degradation of 125I-lysozyme in this system was examined (Fig. 1). 

Phrase: "The effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on ATP-dependent degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1510699:ATP degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "of 125I-lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
   861   C1416945:LYSOZYME [Gene or Genome]
   861   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "in this system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.66: Insulin inhibited ATP-dependent degradation of 125I-lysozyme in a dose-dependent manner, with an apparent IC50 of approximately 50 nM, and with maximal inhibition approximately 92%. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "ATP-dependent degradation of 125I-lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1510699:ATP degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "in a dose-dependent manner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "with an apparent IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "of approximately 50 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and with maximal inhibition approximately 92%."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0205289:Maximal [Qualitative Concept]
   753   C0332232:Approximately [Qualitative Concept]
   753   C0806909:Maximal [Quantitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.67: Under the same conditions, insulin degradation (dotted line) was inhibited with a similar curve (IC50 60 nM), consistent with the action of IDE. 

Phrase: "Under the same conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "inhibited with a similar curve"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205134:Curve [Spatial Concept]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "(IC50 60 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "consistent with the action of IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.68: To further investigate the role of IDE in the ubiquitin pathway, the effect of insulin on 125I-lysozyme degradation in the same system as above was determined in the presence and absence of an inhibitory monoclonal antibody directed against IDE (17, 19). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the role of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the ubiquitin pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on 125I-lysozyme degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "in the same system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "as above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "was"

Phrase: "determined in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "absence of an inhibitory monoclonal antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "directed against IDE"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(17,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.69: In the presence of the antibody, insulin had no effect on ubiquitin- and ATP-dependent activity of the proteasome (Fig. 1B), suggesting that IDE is involved in insulin regulation of this pathway. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "had"

Phrase: "no effect on ubiquitin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "ATP-dependent activity of the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1622946:proteasome activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "involved in insulin regulation of this pathway."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C2984427:Insulin Pathway [Functional Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.70: View larger version (19K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.71: Insulin inhibits ATP- and ubiquitin-dependent degradation of 125I-lysozyme in reticulocyte lysate extract. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ATP-"

Phrase: "and"

Phrase: "ubiquitin-dependent degradation of 125I-lysozyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "in reticulocyte lysate extract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]
Processing 00000000.tx.72: The ATP- and ubiquitin-dependent degradation of 125I-lysozyme in rabbit reticulocyte lysate Fraction II (27 ) was measured by trichloroacetic acid solubility, as described in Materials and Methods. 

Phrase: "The ATP-"

Phrase: "and"

Phrase: "ubiquitin-dependent degradation of 125I-lysozyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "in rabbit reticulocyte lysate Fraction II"

Phrase: "(27"

Phrase: ")"

Phrase: "was"

Phrase: "measured by trichloroacetic acid solubility,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0037628:Solubility [Qualitative Concept]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.73: Data are expressed as percent of maximal activity, mean  SEM for three independent experiments (*, P < 0.05; **, P < 0.01). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as percent of maximal activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0439167:Percent Activity [Quantitative Concept]
           % activity
   753   C0205177:Activity [Functional Concept]
   753   C0205289:Maximal [Qualitative Concept]
   753   C0439165:Percent [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0806909:Maximal [Quantitative Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "mean  SEM for three independent experiments"

Phrase: "("

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.74: A, Solid line and symbols: dose response of insulin inhibition of ATP-dependent degradation of 125I-lysozyme; 

Phrase: "A,"

Phrase: "Solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679214:symbols [Idea or Concept]
   966 E C1698987:symbol [Intellectual Product]

Phrase: ":"

Phrase: "dose response of insulin inhibition of ATP-dependent degradation of 125I-lysozyme"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   751   C1510574:Response Inhibition [Mental Process]
   751   C1512045:Dose-dependent [Quantitative Concept]
   751   C3463820:Response Inhibition [Activity]
   736   C0178602:Dose [Quantitative Concept]
   736   C0869039:Dose [Quantitative Concept]
   736   C0871261:Response [Organism Attribute]
   736   C1114758:Dose # [Clinical Attribute]
   736   C1704632:Response [Finding]
   736   C1706817:Response [Intellectual Product]
   736   C2911692:Response [Mental Process]

Phrase: ";"
Processing 00000000.tx.75: dotted line: degradation of 125I-insulin under the same conditions. 

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ":"

Phrase: "degradation of 125I-insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "under the same conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.76: B, Effect of the inhibitory anti-IDE antibody C203.1A on insulin inhibition of ATP-dependent degradation of 125I-lysozyme.  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Effect of the inhibitory anti-IDE antibody C203.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of ATP-dependent degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1510699:ATP degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "of 125I-lysozyme."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
   861   C1416945:LYSOZYME [Gene or Genome]
   861   C3541379:lysozyme [Enzyme,Pharmacologic Substance]
Processing 00000000.tx.77: Because the ubiquitin pathway of proteolysis requires two separate steps (ubiquitin-conjugation and subsequent degradation), we sought to determine whether insulin decreased the conjugation of ubiquitin to proteins. 

Phrase: "Because"

Phrase: "the ubiquitin pathway of proteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "requires"

Phrase: "two separate steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261552:steps [Conceptual Entity]
   793 E C1704379:Step [Functional Concept]
   793 E C1705117:Step [Quantitative Concept]
   793 E C2825408:Step [Manufactured Object]

Phrase: "(ubiquitin-conjugation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1160466:conjugation [Cell Function]
   789 E C0522529:Conjugated [Spatial Concept]

Phrase: "and"

Phrase: "subsequent degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the conjugation of ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1160466:conjugation [Cell Function]

Phrase: "to proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.78: The same in vitro extract system was used, with the addition of hemin, a potent inhibitor of the proteasome that allows quantification of ubiquitin conjugation (32). 

Phrase: "The same in vitro extract system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "with the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of hemin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018988:Haemin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "a potent inhibitor of the proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   783   C2266856:Proteasome Inhibitor [Molecular Function]
   783   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "that"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "quantification of ubiquitin conjugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.79: The effect of insulin on the conjugation of 125I-ubiquitin to unlabeled lysozyme (as detected by the shift in the migration of 125I-Ub to higher molecular weight species) is shown in the autoradiogram in Fig. 

Phrase: "The effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the conjugation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1160466:conjugation [Cell Function]
   928 E C0522529:Conjugated [Spatial Concept]

Phrase: "of 125I-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to unlabeled lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
   861   C1416945:LYSOZYME [Gene or Genome]
   861   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "("

Phrase: "as"

Phrase: "detected by the shift"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0333051:Shift [Functional Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2347509:Shift [Phenomenon or Process]

Phrase: "in the migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "of 125I-Ub"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to higher molecular weight species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1705920:Species [Conceptual Entity]
   740   C1979900:High molecular weight [Qualitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "shown in the autoradiogram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.80: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.81: Insulin had no effect on ubiquitin conjugation to lysozyme (compare lanes 1 and 3). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "had"

Phrase: "no effect on ubiquitin conjugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "to lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
  1000   C1416945:LYSOZYME [Gene or Genome]
  1000   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.82: The addition of excess unlabeled ubiquitin as a competitor (lanes 2 and 4) reduced the levels of radioactive conjugates nearly to the level present in the absence of ATP (lane 5). 

Phrase: "The addition of excess unlabeled ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "as a competitor"

Phrase: "(lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the levels of radioactive conjugates nearly"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "to the level present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of ATP"

Phrase: "(lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.83: View larger version (45K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.84: Insulin has no effect on the conjugation of 125I-ubiquitin to lysozyme. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "no effect on the conjugation of 125I-ubiquitin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "to lysozyme."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
  1000   C1416945:LYSOZYME [Gene or Genome]
  1000   C3541379:lysozyme [Enzyme,Pharmacologic Substance]
Processing 00000000.tx.85: Conjugation of 125I-Ub to lysozyme was performed as described in Materials and Methods, with and without 1 M insulin. 

Phrase: "Conjugation of 125I-Ub"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1160466:conjugation [Cell Function]

Phrase: "to lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
  1000   C1416945:LYSOZYME [Gene or Genome]
  1000   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "with"

Phrase: "and without 1 M insulin."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1515981:And [Idea or Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.86: A, Equal radioactivity (15 kcpm) was applied to 12% SDS-PAGE. 

Phrase: "A,"

Phrase: "Equal radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "(15 kcpm"

Phrase: ")"

Phrase: "was"

Phrase: "applied to 12% SDS-PAGE."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   853   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   814   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   778   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   774   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0185125:Applied [Health Care Activity]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1704732:Page [Intellectual Product]
   748   C3536965:SULFATE [Element, Ion, or Isotope]
   714 E C1632850:Apply [Functional Concept]
   714 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.87: The migration of 125I- Ub standard (lane 6) is shown (arrow). 

Phrase: "The migration of 125I- Ub standard"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "(lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.88: A contaminant present during the iodination procedure at molecular weight (Mr) of approximately 66,000 shows uniform loading. 

Phrase: "A contaminant present during the iodination procedure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1301671:Present during procedure [Finding]
   774   C0450011:Present procedure [Therapeutic or Preventive Procedure]
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "at molecular weight"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0026385:Molecular Weight [Quantitative Concept]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1521991:Molecular [Qualitative Concept]
   861   C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "(Mr) of approximately 66,000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347167:Mr. [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "uniform loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.89: Lanes 2 and 4 also received excess unlabeled ubiquitin. 

Phrase: "Lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4 also"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "excess unlabeled ubiquitin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.90: B, Quantification of high-Mr (>66,000) radioactivity (arbitrary PhosphorImager units), mean  SEM for three independent experiments.  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Quantification of high-Mr (>66,000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantification [Quantitative Concept]

Phrase: ")"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "(arbitrary PhosphorImager units"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   896   C0439183:Arbitrary unit [Quantitative Concept]
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "mean  SEM for three independent experiments."
Processing 00000000.tx.91: The possibility remained that insulin was itself being conjugated to ubiquitin, which would result in the production of a competitive inhibitor of lysozyme degradation. 

Phrase: "The possibility"

Phrase: "remained"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "itself"

Phrase: "being"

Phrase: "conjugated to ubiquitin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0522529:Conjugated [Spatial Concept]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "which"

Phrase: "would"

Phrase: "result in the production of a competitive inhibitor of lysozyme degradation."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   738   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
   738   C0033268:production [Occupational Activity]
   738   C0243125:degradation [Functional Concept]
   738   C0679932:competitive [Social Behavior]
   738   C0699900:Degradation [Organism Function]
   738   C1274040:Result [Functional Concept]
   738   C1416945:LYSOZYME [Gene or Genome]
   738   C1546471:Result [Idea or Concept]
   738   C1999216:Inhibitor [Qualitative Concept]
   738   C2825142:Result [Finding]
   738   C3541379:lysozyme [Enzyme,Pharmacologic Substance]
Processing 00000000.tx.92: To address this question, 125I-labeled insulin was used with unlabeled ubiquitin, and unlabeled insulin with 125I-labeled ubiquitin under the same conditions, but with the addition of bacitracin, an inhibitor of insulin degradation (33) (Fig. 3). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "125I-labeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "used with unlabeled ubiquitin,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "unlabeled insulin with 125I-labeled ubiquitin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "under the same conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "but with the addition of bacitracin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   753   C0233535:but [Mental or Behavioral Dysfunction]
   753   C1883712:Addition [Functional Concept]

Phrase: "an inhibitor of insulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0021643:insulin inhibitor [Pharmacologic Substance]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(33"

Phrase: ")"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.93: There was no higher molecular weight labeled material in either case, suggesting that insulin is not ubiquitin-conjugated (lanes 16). 

Phrase: "There"

Phrase: "was"

Phrase: "no higher molecular weight"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   983   C1979900:High molecular weight [Qualitative Concept]
   901   C0026385:Molecular Weight [Quantitative Concept]
   896   C0948775:high weight [Sign or Symptom]
   871 E C0424638:Height & weight [Organism Attribute]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "material in either case,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0520510:Material [Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "not ubiquitin-conjugated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0522529:Conjugated [Spatial Concept]
   755 E C1160466:conjugation [Cell Function]

Phrase: "(lanes 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.94: To be sure that bacitracin was not itself interfering with the conjugation process, 125I-ubiquitin was conjugated to lysozyme, as above, in the presence and absence of bacitracin (lanes 79), and no effect by bacitracin itself was seen. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "sure"

Phrase: "that bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "itself"

Phrase: "interfering with the conjugation process,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0521102:interfering [Qualitative Concept]
   760   C1160466:conjugation [Cell Function]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "125I-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "conjugated to lysozyme,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
   790   C0522529:Conjugated [Spatial Concept]
   790   C1416945:LYSOZYME [Gene or Genome]
   790   C3541379:lysozyme [Enzyme,Pharmacologic Substance]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "as"

Phrase: "above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of bacitracin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(lanes 79"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "no effect by bacitracin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "itself"

Phrase: "was"

Phrase: "seen."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]
Processing 00000000.tx.95: View larger version (44K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.96: Ub is not conjugated to insulin. 

Phrase: "Ub"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "conjugated to insulin."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0522529:Conjugated [Spatial Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C0301869:Conjugate [Immunologic Factor]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.97: Ub conjugation was performed as in Fig. 

Phrase: "Ub conjugation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1160466:conjugation [Cell Function]
   789 E C0522529:Conjugated [Spatial Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.98: 2 but with 1 mg/ml bacitracin to reduce insulin degradation. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "but with 1 mg/ml bacitracin to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0439294:mg ml [Quantitative Concept]
   748   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748   C0233535:but [Mental or Behavioral Dysfunction]
   748   C0439269:mg% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "reduce"

Phrase: "insulin degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.99: The presence or absence of ATP is indicated. 

Phrase: "The presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of ATP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "is"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.100: A, Conjugation of ubiquitin to 125I-insulin; 

Phrase: "A,"

Phrase: "Conjugation of ubiquitin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1160466:conjugation [Cell Function]
   718 E C0522529:Conjugated [Spatial Concept]

Phrase: "to 125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.101: B, conjugation of 125I-ubiquitin to insulin; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "conjugation of 125I-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1160466:conjugation [Cell Function]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.102: C, conjugation of 125I-ubiquitin to lysozyme without (lane 7) and with (lane 8) bacitracin. 

Phrase: "C,"

Phrase: "conjugation of 125I-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1160466:conjugation [Cell Function]

Phrase: "to lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
  1000   C1416945:LYSOZYME [Gene or Genome]
  1000   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "without"

Phrase: "(lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "(lane 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "bacitracin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
Processing 00000000.tx.103: As standards, 125I-insulin (lane 3) or 125I-ubiquitin (lanes 6 and 9) alone were also applied.  

Phrase: "As standards,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038137:standards [Intellectual Product]
  1000   C0175675:Standards [Qualitative Concept]
   966 E C1442989:Standard [Qualitative Concept]
   966 E C2828392:Standard [Intellectual Product]

Phrase: "125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "125I-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(lanes 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "9"

Phrase: ")"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "were"

Phrase: "also"

Phrase: "applied."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.104: To observe the influence of insulin in cells, we tested the effect of insulin on the ubiquitin pathway in cultured human hepatoma (HepG2) cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "the influence of insulin"

Phrase: "in cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the ubiquitin pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "in cultured human hepatoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C2239176:Hepatoma [Neoplastic Process]

Phrase: "(HepG2"

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.105: Previous studies showed that treatment of cell cultures with proteasome inhibitors caused an increase in the accumulation of high-molecular-weight ubiquitin-protein conjugates, as determined by immunoblotting with ubiquitin-specific antibodies (34). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that treatment of cell cultures"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "of high-molecular-weight ubiquitin-protein conjugates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0301869:conjugates [Immunologic Factor]

Phrase: "as"

Phrase: "determined by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with ubiquitin-specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.106: Using a similar approach, we examined the accumulation of ubiquitin-protein conjugates in HepG2 cells. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a similar approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the accumulation of ubiquitin-protein"

Phrase: "conjugates in HepG2 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C2717940:HepG2 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0301869:Conjugate [Immunologic Factor]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.107: The levels of ubiquitin-protein conjugates in lysates from treated and untreated cells were monitored by Western blot analysis using an antiubiquitin antibody that is reactive with both free ubiquitin and ubiquitin ligated to proteins (30). 

Phrase: "The levels of ubiquitin-protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "conjugates in lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0301869:Conjugate [Immunologic Factor]
   756   C1881488:Lysate [Physical Object]

Phrase: "from treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "untreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "monitored by Western blot analysis"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antiubiquitin antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "reactive with both free ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205332:Reactive [Qualitative Concept]

Phrase: "and"

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ligated to proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.108: Insulin, at physiologic doses, increased accumulation of high-molecular-weight ubiquitin conjugates (Fig. 4A). 

Phrase: "Insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "at physiologic doses,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "increased accumulation of high-molecular-weight ubiquitin conjugates"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.109: After densitometry and correction for protein loading, the data are quantified in Fig. 

Phrase: "After densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]

Phrase: "and"

Phrase: "correction for protein loading,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705565:CORRECTION [Intellectual Product]
   770   C1947976:Correction [Functional Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "quantified in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.110: 4B. 

Phrase: "4B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]
Processing 00000000.tx.111: Insulin treatment resulted in an 80% increase in the level of ubiquitin-protein conjugates at 1.0 nM insulin. 

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in an 80% increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442805:Increase [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of ubiquitin-protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "conjugates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301869:Conjugate [Immunologic Factor]

Phrase: "at 1.0 nM insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.112: View larger version (32K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.113: Insulin increases accumulation of ubiquitin-protein conjugates in HepG2 cells. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "accumulation of ubiquitin-protein"

Phrase: "conjugates in HepG2 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C2717940:HepG2 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0301869:Conjugate [Immunologic Factor]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.114: HepG2 cells were treated with the indicated amounts of insulin (Ins) for 2 h, then lysates were prepared and analyzed by Western blotting with C59 ubiquitin-specific antibody and a tubulin-specific antibody, as described in Materials and Methods. 

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with the indicated amounts of insulin (Ins)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1265611:amounts [Quantitative Concept]
   748   C1444656:Indicated [Finding]
   748   C1522326:Treated [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "for 2 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "then lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with C59 ubiquitin-specific antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "a tubulin-specific antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.115: A, Ub immunoreactive proteins were detected by enhanced chemiluminescence. 

Phrase: "A,"

Phrase: "Ub immunoreactive proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected by enhanced chemiluminescence."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0442726:Detected [Finding]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2349975:Enhanced [Activity]
Processing 00000000.tx.116: As a loading control, the same blot was reprobed with an antitubulin monoclonal antibody (bottom panel). 

Phrase: "As a loading control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "the same blot"

Phrase: "was"

Phrase: "reprobed with an antitubulin monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.117: B, High Mr (>116,000) was quantified by densitometry and corrected for protein loading. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "High Mr (>116,000"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205250:High [Qualitative Concept]
   812   C1299351:High [Qualitative Concept]
   812   C2347167:Mr. [Conceptual Entity]
   812   C2700149:HIGH [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "quantified by densitometry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "and"

Phrase: "corrected for protein loading."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205202:Corrected [Qualitative Concept]
   770   C1708715:Loading [Activity]
   737 E C2349182:Correct [Qualitative Concept]
Processing 00000000.tx.118: Data are the arbitrary densitometer units, means  SEM (n = 4).  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "the arbitrary densitometer units,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   896   C0439183:Arbitrary unit [Quantitative Concept]
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: "means  SEM (n = 4"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C1704970:Means [Conceptual Entity]
   779 E C0444504:Mean [Quantitative Concept]
   779 E C2347634:Mean [Quantitative Concept]
   779 E C2348143:Mean [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.119: Previous studies, using purification schemes designed for the isolation of IDE, revealed copurification of the proteasome with IDE from skeletal muscle extracts (16, 17). 

Phrase: "Previous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "purification schemes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519193:Scheme [Intellectual Product]

Phrase: "designed for the isolation of IDE,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0204727:Isolation [Therapeutic or Preventive Procedure]
   744   C0205409:Isolation [Functional Concept]
   744   C0220862:isolation [Laboratory Procedure]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   711   C1707689:Design [Activity]
   711   C2983265:DESIGN [Intellectual Product]

Phrase: "revealed copurification of the proteasome"

Phrase: "with IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "from skeletal muscle extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C2828366:Extract [Substance]
   734   C0242692:Muscle, Skeletal [Tissue]
   734   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.120: Because insulin inhibited the ubiquitin pathway, we sought to examine the relationship between IDE and the 26S proteasome. 

Phrase: "Because"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the ubiquitin pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the relationship between IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "the 26S proteasome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.121: Using a purification series designed for the enrichment of the 26S proteasome (31), proteasome activity, measured with the fluorogenic peptide substrate LLVY, copurified with insulin-degrading activity (Table 1). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a purification series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "designed for the enrichment of the 26S proteasome"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1166804:26S proteasome [Cell Component]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1325620:proteasome [Cell Component]
   744   C1552140:26s [Body Part, Organ, or Organ Component]
   744   C1752727:Proteasome [Molecular Function]
   711   C1707689:Design [Activity]
   711   C2983265:DESIGN [Intellectual Product]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "proteasome activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "measured with the fluorogenic peptide substrate LLVY,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   774   C0016349:Fluorogenic Substrate [Indicator, Reagent, or Diagnostic Aid]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0444706:Measured [Qualitative Concept]
   748   C1710236:Substrate [Manufactured Object]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "copurified with insulin-degrading activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.122: Similarly, IDE immunoreactive material (Fig. 5, upper panel) increased with each level of purification, in parallel with the level of proteasome-immunoreactive material (lower panel). 

Phrase: "Similarly,"

Phrase: "IDE immunoreactive material"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0520510:Material [Substance]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "increased with each level of purification,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205217:Increased [Quantitative Concept]
   753   C0243114:purification [Functional Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1998793:Purification [Functional Concept]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "in parallel with the level of proteasome-immunoreactive material"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0150312:In [Quantitative Concept]
   742   C0332285:In [Spatial Concept]
   742   C2348042:Parallel [Qualitative Concept]
   742   C2826345:PARALLEL [Research Activity]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.123: In the final 100,000 x g centrifugation step, most of the LLVY-degrading activity and proteasome immunoreactivity was present in the pellet, whereas insulin-degrading activity and IDE immunoreactive material distributed to both the supernatant and pellet. 

Phrase: "In the final 100,000 x g centrifugation step,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C1261552:Step [Conceptual Entity]
   795   C1704379:Step [Functional Concept]
   795   C1705117:Step [Quantitative Concept]
   795   C2825408:Step [Manufactured Object]

Phrase: "most of the LLVY-degrading activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205177:Activity [Functional Concept]
   753   C0205393:Most [Quantitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "proteasome immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "present in the pellet,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "whereas"

Phrase: "insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IDE immunoreactive material"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0520510:Material [Substance]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "distributed to both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704711:Distributed [Functional Concept]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellet."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]
Processing 00000000.tx.124: The distribution of IDE in the pellet (19.5% of the total activity, 53.3% of the total immunoreactivity) was much higher than that expected from simple contamination of the pellet (4.0% of the total volume). 

Phrase: "The distribution of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in the pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "(19.5% of the total activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "53.3% of the total immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: ")"

Phrase: "was"

Phrase: "much higher than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "expected from simple contamination of the pellet"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0205352:Simple [Qualitative Concept]
   748   C0259846:contamination [Human-caused Phenomenon or Process]
   748   C0441436:Pellet [Manufactured Object]
   748   C0993610:Pellet [Biomedical or Dental Material]
   748   C1517001:Expected [Idea or Concept]
   748   C1881659:CONTAMINATION [Event]
   748   C1998480:Pellet [Quantitative Concept]
   748   C2349974:Contamination [Idea or Concept]

Phrase: "(4.0% of the total volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0449468:Total Volume [Quantitative Concept]
           *Volume
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.125: These data suggest the existence of two subpopulations, both free IDE and proteasome-associated IDE, in these preparations. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the existence of two subpopulations,"

Phrase: "both free IDE"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   861   C0523720:free insulin [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "proteasome-associated IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in these preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.126: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.127: Copurification of IDE and proteasome activities in a skeletal muscle 26S proteasome purification scheme  View larger version (56K): [in this window] [in a new window]  Figure 5. 

Phrase: "Copurification of IDE"

Phrase: "and"

Phrase: "proteasome activities in a skeletal muscle 26S proteasome purification scheme"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   743   C1622946:proteasome activity [Molecular Function]
   739   C0441655:Activities [Activity]
   706 E C0205177:Activity [Functional Concept]
   706 E C0439167:% activity [Quantitative Concept]
   706 E C1561536:*Activity [Idea or Concept]
   705   C0231484:Muscular activity [Organ or Tissue Function]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(56K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.128: Copurification of IDE with the 26S proteasome. 

Phrase: "Copurification of IDE"

Phrase: "with the 26S proteasome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.129: Rat skeletal muscle extract was purified as described in Materials and Methods. 

Phrase: "Rat skeletal muscle extract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2828366:Extract [Substance]
   756   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.130: Equal amounts of protein were applied to 7.5% (upper panel) or 12.0% (lower panel) SDS-PAGE and analyzed by Western blotting for the presence of IDE or proteasome, using the 9B12 monoclonal anti-IDE antibody or anti-20S proteasome polyclonal antiserum, as described in Materials and Methods.  

Phrase: "Equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "applied to 7.5%"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0185125:Applied [Health Care Activity]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "12.0%"

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "SDS-PAGE"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   923   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1704732:Page [Intellectual Product]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "for the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 9B12 monoclonal anti-IDE antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   868   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   861   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "anti-20S proteasome polyclonal antiserum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.131: To explore this further, both the supernatant and pellet from the 100,000 x g spin were applied to 1040% glycerol gradients. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "this further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "both"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellet from the 100,000 x g spin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0441436:Pellet [Manufactured Object]
   744   C0993610:Pellet [Biomedical or Dental Material]
   744   C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "applied to 1040% glycerol gradients."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C0185125:Applied [Health Care Activity]
   760   C0812409:gradients [Quantitative Concept]
   726 E C0439182:% gradient [Quantitative Concept]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.132: With the 100,000 x g supernatant, the SDS-activated LLVY-degrading activity sediments, as a single peak in the 20S region (Fig. 6A), corresponding to proteasome-immunoreactive material (Fig. 6B). 

Phrase: "With the 100,000 x g supernatant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1550101:Supernatant [Body Substance]

Phrase: "the SDS-activated LLVY-degrading activity sediments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550099:Sediment [Body Substance]

Phrase: "as"

Phrase: "a single peak in the 20S region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0444505:Peak [Quantitative Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "corresponding to proteasome-immunoreactive material"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0520510:Material [Substance]
   760   C1325620:proteasome [Cell Component]
   760   C1752727:Proteasome [Molecular Function]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.133: Insulin-degrading activity and IDE immunoreactivity sediment in a separate peak. 

Phrase: "Insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IDE immunoreactivity sediment in a separate peak."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1550099:Sediment [Body Substance]
Processing 00000000.tx.134: In the 100,000 x g pellet, LLVY-degrading activity (Fig. 7A) was present in both an SDS-activated peak, consistent with the 20S proteasome (as in Fig. 6A), and shoulder of SDS-insensitive activity, consistent with the 26S proteasome. 

Phrase: "In the 100,000 x g pellet,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441436:Pellet [Manufactured Object]
   804   C0993610:Pellet [Biomedical or Dental Material]
   804   C1998480:Pellet [Quantitative Concept]

Phrase: "LLVY-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "was"

Phrase: "present in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "an SDS-activated peak,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0444505:Peak [Quantitative Concept]
   717   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]

Phrase: "consistent with the 20S proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "("

Phrase: "as in Fig. 6A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   770   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "shoulder of SDS-insensitive activity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037004:Shoulder [Body Location or Region]
   748   C1283792:Shoulder [Body Location or Region]

Phrase: "consistent with the 26S proteasome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.135: Proteasome immunoreactivity was present in both areas. 

Phrase: "Proteasome immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "present in both areas."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.136: Insulin-degrading activity and IDE immunoreactivity were present in two distinct peaks, one of which cosedimented with the 20S proteasome region. 

Phrase: "Insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IDE immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0597879:immunoreactivity [Molecular Function]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "were"

Phrase: "present in two distinct peaks,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "cosedimented with the 20S proteasome region."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
   790   C1166808:20S proteasome [Cell Component]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C1325620:proteasome [Cell Component]
   753   C1552134:20s [Body Part, Organ, or Organ Component]
   753   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.137: A small amount of insulin-degrading activity was present in the 26S region, and IDE immunoreactive material was detected in the 26S region, on overexposure of the blots (not shown). 

Phrase: "A small amount of insulin-degrading activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "present in the 26S region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "IDE immunoreactive material"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0520510:Material [Substance]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "was"

Phrase: "detected in the 26S region,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1552140:26s [Body Part, Organ, or Organ Component]

Phrase: "on overexposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0848174:over-exposure [Injury or Poisoning]

Phrase: "of the blots"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: The other peak of insulin-degrading activity and IDE immunoreactivity sedimented in the same region of the gradient as that of the 100,000 x g supernatant material (compare with Fig. 6). 

Phrase: "The"

Phrase: "other peak of insulin-degrading activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0444505:Peak [Quantitative Concept]

Phrase: "and"

Phrase: "IDE immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0597879:immunoreactivity [Molecular Function]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "sedimented in the same region of the gradient"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0439182:% gradient [Quantitative Concept]
   744   C0445247:Same [Qualitative Concept]
   744   C0812409:Gradient [Quantitative Concept]
   711   C1550099:Sediment [Body Substance]

Phrase: "as that"

Phrase: "of the 100,000 x g supernatant material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Material [Substance]

Phrase: "("

Phrase: "compare with Fig. 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   770   C1707455:Compare [Activity]

Phrase: ")."
Processing 00000000.tx.139: Therefore, the data suggest that IDE, in the 100,000 x g pellet, consists of both proteasome-associated and free IDE, whereas the IDE in the 100,000 x g supernatant consists of a single species not associated with the proteasome. 

Phrase: "Therefore,"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the 100,000 x g pellet,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441436:Pellet [Manufactured Object]
   804   C0993610:Pellet [Biomedical or Dental Material]
   804   C1998480:Pellet [Quantitative Concept]

Phrase: "consists of both proteasome-associated"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332281:Associated [Qualitative Concept]
   760   C0332529:CONSIST [Qualitative Concept]
   760   C1325620:proteasome [Cell Component]
   760   C1752727:Proteasome [Molecular Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "free IDE,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   861   C0523720:free insulin [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "whereas"

Phrase: "the IDE in the 100,000 x g supernatant"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   775   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   775   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   754   C2265200:G enzyme [Molecular Function]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]

Phrase: "consists of a single species"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0332529:CONSIST [Qualitative Concept]
   760   C1705920:Species [Conceptual Entity]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with the proteasome."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.140: View larger version (31K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.141: Glycerol gradient analysis of 100,000 x g supernatant. 

Phrase: "Glycerol gradient analysis of 100,000 x g supernatant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
Processing 00000000.tx.142: The 100,000 x g supernatant step of the 26S purification series was applied to a 1040% glycerol gradient. 

Phrase: "The 100,000 x g supernatant step of the 26S purification series"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C1261552:Step [Conceptual Entity]
   736   C1704379:Step [Functional Concept]
   736   C1705117:Step [Quantitative Concept]
   736   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "applied to a 1040% glycerol gradient."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   753   C0185125:Applied [Health Care Activity]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.143: A, Fractions were assayed for insulin-degrading activity () or LLVY-degrading activity in the presence of 0.02% SDS (). 

Phrase: "A,"

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "assayed for insulin-degrading activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "LLVY-degrading activity in the presence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "of 0.02% SDS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   853   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   840   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0038720:Sulfate [Inorganic Chemical]
   804   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.144: There was no detectable LLVY-degrading activity without SDS. 

Phrase: "There"

Phrase: "was"

Phrase: "no detectable LLVY-degrading activity without SDS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.145: The regions of sedimentation of 26S and 20S proteasome are indicated. 

Phrase: "The regions of sedimentation of 26S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.146: B, The fractions were analyzed by 7.5% (upper panel) or 12.0% (lower panel) SDS-PAGE and Western blotting to detect the presence of IDE (upper panel) or proteasome (lower panel) using the 9B12 monoclonal anti-IDE antibody or anti-20S proteasome polyclonal antiserum, as described in Materials and Methods.  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by 7.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "12.0%"

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "SDS-PAGE"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   923   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1704732:Page [Intellectual Product]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Western blotting to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the presence of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 9B12 monoclonal anti-IDE antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   868   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   861   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "anti-20S proteasome polyclonal antiserum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.147: View larger version (33K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.148: Glycerol gradient analysis of 100,000 x g pellet. 

Phrase: "Glycerol gradient analysis of 100,000 x g pellet."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
Processing 00000000.tx.149: The 100,000 x g pellet step of the 26S purification series was applied to a 1040% glycerol gradient. 

Phrase: "The 100,000 x g pellet step of the 26S purification series"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C1261552:Step [Conceptual Entity]
   736   C1704379:Step [Functional Concept]
   736   C1705117:Step [Quantitative Concept]
   736   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "applied to a 1040% glycerol gradient."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   753   C0185125:Applied [Health Care Activity]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.150: A, Fractions were assayed for insulin-degrading activity () or LLVY-degrading activity in the absence () or presence () of 0.02% SDS. 

Phrase: "A,"

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "assayed for insulin-degrading activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "LLVY-degrading activity in the absence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "of 0.02% SDS."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   853   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   840   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0038720:Sulfate [Inorganic Chemical]
   804   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.151: Regions of sedimentation of 26S and 20S proteasome are indicated. 

Phrase: "Regions of sedimentation of 26S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.152: B, The fractions were analyzed by 7.5% (upper panel) or 12.0% (lower panel) SDS-PAGE and Western blotting to detect the presence of IDE (upper panel) or proteasome (lower panel) using the 9B12 monoclonal anti-IDE antibody or anti-20S proteasome polyclonal antiserum, as described in Materials and Methods.  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by 7.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "12.0%"

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "SDS-PAGE"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   923   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1704732:Page [Intellectual Product]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Western blotting to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the presence of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 9B12 monoclonal anti-IDE antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   868   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   861   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "anti-20S proteasome polyclonal antiserum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.153: The demonstration of IDE associated with the proteasome supports our previous reports suggesting that IDE mediates inhibition of the proteasome by insulin (19, 20, 21). 

Phrase: "The demonstration of IDE"

Phrase: "associated with the proteasome"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "inhibition of the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(19,"

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.154: A possible mechanism for this insulin action might be alteration of IDE association with the proteasome. 

Phrase: "A possible mechanism for this insulin action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "might"

Phrase: "be"

Phrase: "alteration of IDE association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: "with the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.155: If this were the case, then insulin treatment of the IDE-proteasome complex (100,000 x g pellet) would displace IDE from the proteasome and alter its sedimentation pattern. 

Phrase: "If"

Phrase: "this"

Phrase: "were"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "then insulin treatment of the IDE-proteasome complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "(100,000 x g pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441436:Pellet [Manufactured Object]
   804   C0993610:Pellet [Biomedical or Dental Material]
   804   C1998480:Pellet [Quantitative Concept]

Phrase: ")"

Phrase: "would"

Phrase: "displace"

Phrase: "IDE from the proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "its sedimentation pattern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.156: To test this hypothesis, the 100,000 x g pellet was incubated with and without 1 nM insulin, then analyzed by glycerol gradients (Fig. 8). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "the 100,000 x g pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441436:Pellet [Manufactured Object]
   804   C0993610:Pellet [Biomedical or Dental Material]
   804   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "and without 1 nM insulin,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1515981:And [Idea or Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by glycerol gradients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0812409:gradients [Quantitative Concept]
   770   C0936012:Analyzed [Research Activity]
   737 E C0439182:% gradient [Quantitative Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.157: Without insulin, insulin-degrading activity sedimented with the same profile as in Fig. 

Phrase: "Without insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "sedimented with the same profile"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0445247:Same [Qualitative Concept]
   760   C1979963:Profile [Laboratory Procedure]
   760   C2003903:Profile [Functional Concept]
   726   C1550099:Sediment [Body Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.158: 7, but 1 nM insulin caused IDE to sediment almost completely as the free form. 

Phrase: "7,"

Phrase: "but"

Phrase: "1 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "IDE to sediment almost completely"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "as the free form."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0332296:free [Functional Concept]
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
Processing 00000000.tx.159: Insulin has no effect on the sedimentation of SDS-sensitive proteasome activity (dotted line). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "no effect on the sedimentation of SDS-sensitive proteasome activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1301751:No effect [Qualitative Concept]
   736   C1280500:Effect [Qualitative Concept]
   736   C2348382:Effect [Qualitative Concept]

Phrase: "(dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.160: This shift in the sedimentation profile of IDE is reflected in Western blots of IDE. 

Phrase: "This shift in the sedimentation profile of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0333051:Shift [Functional Concept]
   739   C2347509:Shift [Phenomenon or Process]

Phrase: "is"

Phrase: "reflected in Western blots of IDE."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   770   C0949466:Western Blots [Laboratory Procedure]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0558058:reflected [Mental Process]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1705493:Western [Spatial Concept]
   737 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.161: This finding suggests that insulin treatment displaces IDE from the proteasome and produces predominantly a single species, of IDE, not associated with the proteasome. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "displaces"

Phrase: "IDE from the proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "produces"

Phrase: "predominantly"

Phrase: "a single species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "of IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with the proteasome."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.162: View larger version (37K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.163: Displacement of IDE from the proteasome by insulin treatment. 

Phrase: "Displacement of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012725:Displacement [Mental Process]
   760   C0012727:Displacement [Spatial Concept]
   760   C0456080:Displacement [Qualitative Concept]
   760   C2347509:Displacement [Phenomenon or Process]

Phrase: "from the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "by insulin treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.164: Glycerol density gradients of 100,000 x g pellet were treated without and with 1 nM insulin for 2 h at 37 C. 

Phrase: "Glycerol density gradients of 100,000 x g pellet"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0178587:density [Quantitative Concept]
   742   C0812409:gradients [Quantitative Concept]
   708 E C0439182:% gradient [Quantitative Concept]

Phrase: "were"

Phrase: "treated without"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332293:treated [Therapeutic or Preventive Procedure]
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "and with 1 nM insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1515981:And [Idea or Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C."
Processing 00000000.tx.165: A, The level of insulin-degrading activity was measured in the absence () or presence () of insulin. 

Phrase: "A,"

Phrase: "The level of insulin-degrading activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0202098:Insulin level [Laboratory Procedure]
   783   C0428405:insulin level [Laboratory or Test Result]
   783   C0683317:Activity level [Finding]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured in the absence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "of insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.166: The level of SDS-activated proteasome activity is indicated by the dotted line. 

Phrase: "The level of SDS-activated proteasome activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0428291:Sodium level [Laboratory or Test Result]
   762   C0474702:Sulfate level [Laboratory Procedure]
   762   C0683317:Activity level [Finding]
   762   C1304770:Sulphate level [Laboratory or Test Result]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "indicated by the dotted line."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205132:Line [Spatial Concept]
   760   C1444656:Indicated [Finding]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   726   C0872145:DOT [Therapeutic or Preventive Procedure]
Processing 00000000.tx.167: B, Fractions from the glycerol gradients were probed for IDE and proteasome by Western blotting using the 9B12 monoclonal anti-IDE antibody or anti-20S proteasome polyclonal antiserum, as described in Materials and Methods.   

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Fractions from the glycerol gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "probed for IDE"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "proteasome by Western blotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 9B12 monoclonal anti-IDE antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   868   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   861   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "anti-20S proteasome polyclonal antiserum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.168: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  In this study, we have expanded our previous findings of insulin regulation of proteasome activity (17, 18) to the ubiquitin-proteasome pathway, a system involved in a number of critical cellular processes, including transcription factor regulation, antigen presentation, and cell cycle control (see Ref. 8 for review). 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "our previous findings of insulin regulation of proteasome activity"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   742   C2607943:findings [Functional Concept]
   742   C2926606:Findings [Clinical Attribute]
   742   C3539655:Findings [Intellectual Product]
   708 E C0037088:Finding [Sign or Symptom]
   708 E C0243095:Finding [Finding]
   708 E C2825141:Finding [Finding]

Phrase: "(17,"

Phrase: "18"

Phrase: ")"

Phrase: "to the ubiquitin-proteasome pathway,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   976   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   901   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   865 E C1523807:proteasomal pathway [Molecular Function]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "a system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "involved in a number of critical cellular processes,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   754   C0007613:Cellular Process [Cell Function]
   754   C1325880:cellular process [Cell Function]
   744   C0007634:Cellular [Cell]
   744   C0178539:Cellular [Functional Concept]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1511545:Critical [Qualitative Concept]
   711   C1184743:Process [Body Part, Organ, or Organ Component]
   711   C1522240:Process [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "transcription factor regulation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1158770:Transcription Regulation [Genetic Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "antigen presentation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0206431:Antigen Presentation [Cell Function]
   861   C0003320:Antigen [Immunologic Factor]
   861   C0449450:Presentation [Idea or Concept]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "and"

Phrase: "cell cycle control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1155872:Cell Cycle Control [Cell Function]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 8 for review"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282443:Review [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.169: Insulin inhibited ATP- and ubiquitin-dependent degradation in an in vitro extract, at concentrations similar to those seen previously for peptide degradation by the proteasome (17). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "ATP-"

Phrase: "and"

Phrase: "ubiquitin-dependent degradation in an in vitro extract,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "previously for peptide degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1523817:peptide degradation [Molecular Function]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "by the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.170: Furthermore, the inhibition correlated with the level of insulin degradation in the system and was eliminated in the presence of an anti-IDE antibody, suggesting the involvement of IDE. 

Phrase: "Furthermore,"

Phrase: "the inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "correlated with the level of insulin degradation"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C3547574:insulin degradation [Molecular Function]
   774   C0202098:Insulin level [Laboratory Procedure]
   774   C0428405:insulin level [Laboratory or Test Result]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0243125:degradation [Functional Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0699900:Degradation [Organism Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1547707:Level [Geographic Area]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1707520:Correlated [Qualitative Concept]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in the system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "eliminated in the presence of an anti-IDE antibody,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   775   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   775   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   772   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   754   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C0849355:Eliminated [Qualitative Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the involvement of IDE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.171: Although the IC50 for inhibition by insulin (50 nM) was somewhat high, relative to circulating levels of insulin (10 pM to 1 nM), the lysozyme degradation assay is slow, and it requires enzyme levels above those for optimal enzyme-substrate kinetics (22). 

Phrase: "Although"

Phrase: "the IC50 for inhibition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0600495:IC50 [Quantitative Concept]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(50 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "was"

Phrase: "somewhat high, relative to circulating levels of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "(10 pM to 1 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1441094:PM-1 [Immunologic Factor]

Phrase: "the lysozyme degradation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "slow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slow [Qualitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "requires"

Phrase: "enzyme levels above those for optimal enzyme-substrate kinetics"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0014440:enzyme levels [Laboratory Procedure]
   764   C1287349:enzyme levels [Laboratory or Test Result]
   762   C0178623:enzyme substrate [Chemical Viewed Functionally]
   762   C1516893:Enzyme Kinetics [Occupation or Discipline]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.172: On the other hand, the cell culture experiments (Fig. 4) showed insulin inhibition of the ubiquitin pathway well within the physiological range of insulin. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the cell culture experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "insulin inhibition of the ubiquitin pathway well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "within the physiological range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "of insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.173: Because the ubiquitin-proteasome pathway requires conjugation of ubiquitin to substrates, insulin could have been inhibiting the ubiquitin-conjugation step, but our results showed that insulin, at doses sufficient to inhibit proteolysis, did not reduce ubiquitin conjugation to the substrate protein (Fig. 2), and there was no evidence of the formation of competitive ubiquitin-insulin conjugates (Fig. 3). 

Phrase: "Because"

Phrase: "the ubiquitin-proteasome pathway"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   976   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   901   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   865 E C1523807:proteasomal pathway [Molecular Function]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "requires"

Phrase: "conjugation of ubiquitin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1160466:conjugation [Cell Function]
   718 E C0522529:Conjugated [Spatial Concept]

Phrase: "to substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "could"

Phrase: "have"

Phrase: "been"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the ubiquitin-conjugation step,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "but"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "at doses sufficient to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0178602:Doses [Quantitative Concept]
   793 E C0869039:Dose [Quantitative Concept]
   793 E C1114758:Dose # [Clinical Attribute]
   793 E C1428722:DOS [Gene or Genome]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "proteolysis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "ubiquitin conjugation to the substrate protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1160466:conjugation [Cell Function]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "no evidence of the formation of competitive ubiquitin-insulin conjugates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.174: This leaves the degradation step as the site of action by insulin. 

Phrase: "This"

Phrase: "leaves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242724:Leaves [Plant]

Phrase: "the degradation step as the site of action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1261552:Step [Conceptual Entity]
   744   C1704379:Step [Functional Concept]
   744   C1705117:Step [Quantitative Concept]
   744   C2825408:Step [Manufactured Object]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.175: In cultured cells, physiological levels of insulin induced the accumulation of ubiquitin-protein conjugates (Fig. 4), consistent with inhibition of the ubiquitin-dependent degradation pathway. 

Phrase: "In cultured cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "physiological levels of insulin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   819   C0202098:insulin levels [Laboratory Procedure]
   819   C0428405:insulin levels [Laboratory or Test Result]
   770   C0205463:Physiological [Functional Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the accumulation of ubiquitin-protein conjugates"

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "consistent with inhibition of the ubiquitin-dependent degradation pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.176: There are several possible mechanisms for insulin regulation of proteasome activity. 

Phrase: "There"

Phrase: "are"

Phrase: "several possible mechanisms for insulin regulation of proteasome activity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0441712:Mechanisms [Functional Concept]
   708 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.177: Insulin has been implicated in the control of levels of mRNA for ubiquitin, proteasome, and ubiquitin-conjugating enzyme (35, 36, 37), but this has been suggested to be via activation of the insulin-like growth factor (IGF)-I receptor (38). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the control of levels of mRNA"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243148:control [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "for ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "ubiquitin-conjugating enzyme"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0084913:Ubiquitin-conjugating enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0301869:Conjugate [Immunologic Factor]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(35,"

Phrase: "36,"

Phrase: "37"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "this"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be via activation of the insulin-like growth factor (IGF)-I receptor"
Meta Candidates (Total=29; Excluded=0; Pruned=0; Remaining=29)
   846   C0140080:Insulin-Like-Growth Factor I Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   846   C1334088:INSULIN-LIKE GROWTH FACTOR I RECEPTOR [Gene or Genome]
   820   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   813   C0140079:Insulin-Like Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   797   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   797   C1753359:insulin-like growth factor [Molecular Function]
   772   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   772   C2249824:activation of growth [Organism Function]
   756   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   754   C1334133:INSULIN RECEPTOR [Gene or Genome]
   754   C1514758:Receptor Activation [Cell Function]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0021966:I- [Inorganic Chemical]
   738   C0220844:growth [Physiologic Function]
   738   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C1521761:Factor [Functional Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C1879547:Activation [Activity]
   738   C2827422:Factor [Conceptual Entity]
   738   C2911660:Growth [Activity]
   738   C2987476:Be [Conceptual Entity]
   726   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.178: Though these mechanisms may indeed contribute to insulin regulation of proteolysis, they do not explain how insulin inhibits the ubiquitin-proteasome pathway using in vitro cell extracts, nor do they explain rapid regulation of cellular proteolysis by insulin. 

Phrase: "Though"

Phrase: "these mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "indeed"

Phrase: "contribute to insulin regulation of proteolysis,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1514825:Regulation of Proteolysis [Molecular Function]
           Proteolytic Regulation
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0597304:Proteolysis [Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1880177:Contribute [Activity]

Phrase: "they"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "how insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the ubiquitin-proteasome pathway"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   976   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   901   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   865 E C1523807:proteasomal pathway [Molecular Function]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in vitro cell extracts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007592:Cell Extracts [Cell Component]
   779   C2828366:Extract [Substance]

Phrase: "nor"

Phrase: "do"

Phrase: "they"

Phrase: "explain"

Phrase: "rapid regulation of cellular proteolysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1514825:Regulation of Proteolysis [Molecular Function]
           Proteolytic Regulation
   797   C0596286:Cellular Regulation [Cell Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.179: Another possibility is phosphorylation of the proteasome, in response to insulin, although the effect of phosphorylation on proteasome catalytic activity is conflicting (39, 40, 41). 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "phosphorylation of the proteasome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "although"

Phrase: "the effect of phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on proteasome catalytic activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C1622946:proteasome activity [Molecular Function]
   901   C0243102:catalytic activity [Molecular Function]
   901   C1264638:Catalytic activity [Functional Concept]
   901   C1547012:*Catalytic Activity [Quantitative Concept]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "conflicting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009671:conflicting [Individual Behavior]
   966 E C1705242:Conflict [Qualitative Concept]

Phrase: "(39,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.180: Again, this mechanism is not supported by the earlier in vitro studies, because phosphorylation should not occur under these conditions. 

Phrase: "Again,"

Phrase: "this mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "supported by the earlier in vitro studies,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   797   C0681828:in vitro study [Research Activity]
           studies vitro
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0947630:studies [Laboratory Procedure]
   748   C1521721:Supported [Conceptual Entity]
   714 E C0183683:Support [Medical Device]
   714 E C0557651:Study [Manufactured Object]
   714   C1279919:Early [Temporal Concept]
   714 E C2603343:Study [Research Activity]

Phrase: "because"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur under these conditions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.181: A novel possibility is that insulin may inhibit the proteasome through an associated protein, IDE. 

Phrase: "A novel possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the proteasome through an associated protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1325620:proteasome [Cell Component]
   753   C1752727:Proteasome [Molecular Function]

Phrase: "IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.182: The catalytic properties of the proteasome can vary widely, depending on its association with regulatory proteins (42). 

Phrase: "The catalytic properties of the proteasome"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "can"

Phrase: "vary"

Phrase: "widely,"

Phrase: "depending on its association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   737   C0725813:depend [Medical Device]

Phrase: "with regulatory proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.183: Previously, we showed insulin inhibition of the proteasome in vitro and in cultured cells (17, 18, 19, 21). 

Phrase: "Previously,"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "insulin inhibition of the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and in cultured cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C1515981:And [Idea or Concept]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(17,"

Phrase: "18,"

Phrase: "19,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.184: Removal of IDE from the extracts or introduction of a neutralizing antibody into cells resulted in a loss of insulin regulation of the proteasome (17, 19, 21). 

Phrase: "Removal of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from the extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "or"

Phrase: "introduction of a neutralizing antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1293116:Introduction [Health Care Activity]
   760   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "into cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "resulted in a loss of insulin regulation of the proteasome"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1325620:proteasome [Cell Component]
   739   C1327622:Regulation [Biologic Function]
   739   C1517945:Loss [Quantitative Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1752727:Proteasome [Molecular Function]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "(17,"

Phrase: "19,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.185: In the present study, using a preparation designed to enrich for the 26S proteasome from muscle, we found copurification of IDE by both insulin-degrading activity (Table 2) and by detection with an IDE-specific antibody (Fig. 5). 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "designed to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "enrich for the 26S proteasome"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1166804:26S proteasome [Cell Component]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0359583:Enrich [Food]
   760   C1325620:proteasome [Cell Component]
   760   C1552140:26s [Body Part, Organ, or Organ Component]
   760   C1752727:Proteasome [Molecular Function]

Phrase: "from muscle,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "copurification of IDE"

Phrase: "by both insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "and by detection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]
   790   C1515981:And [Idea or Concept]

Phrase: "with an IDE-specific antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C0021644:Insulin antibody [Immunologic Factor]
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.186: Although this purification series is designed to purify 26S proteasome, glycerol gradient analysis of the 100,000 x g pellet showed that the majority of the proteasome sedimented in the 20S region, with much less in the 26S region, a result of rapid equilibration between the two forms, as shown previously (43). 

Phrase: "Although"

Phrase: "this purification series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "is"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "26S proteasome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "glycerol gradient analysis of the 100,000 x g pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the majority of the proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "sedimented in the 20S region,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C1552134:20s [Body Part, Organ, or Organ Component]
   726   C1550099:Sediment [Body Substance]

Phrase: "with much less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "in the 26S region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "a result of rapid equilibration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "between the two forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "as"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.187: In this 100,000 x g preparation, IDE was found to cosediment with the 20S proteasome on glycerol gradients (Fig. 7), as well as with the 26S form when the blots were overexposed. 

Phrase: "In this 100,000 x g preparation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0455052:Preparation [Health Care Activity]
   804   C1521827:Preparation [Functional Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "found to cosediment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "with the 20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "on glycerol gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0812409:gradients [Quantitative Concept]
   827 E C0439182:% gradient [Quantitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "as well as with the 26S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205170:Well [Qualitative Concept]
   753   C1552140:26s [Body Part, Organ, or Organ Component]
   753   C3146287:Well [Manufactured Object]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "when"

Phrase: "the blots"

Phrase: "were"

Phrase: "overexposed."
Processing 00000000.tx.188: Because of the rapid dissociation of the 26S proteasome, attempts to reapply the 26S-sedimenting material to conclusively show IDE association were unsuccessful, and thus the possibility that the IDE detected in the 26S region is caused by contamination by 20S-associated IDE cannot be ruled out. 

Phrase: "Because of the rapid dissociation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "of the 26S proteasome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reapply"

Phrase: "the 26S-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552140:26s [Body Part, Organ, or Organ Component]

Phrase: "sedimenting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550099:Sediment [Body Substance]

Phrase: "material to conclusively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Material [Substance]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "IDE association"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0004083:Association [Mental Process]
   812   C0439849:Association [Qualitative Concept]
   812   C0596306:Association [Phenomenon or Process]
   812   C0699792:association [Social Behavior]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "were"

Phrase: "unsuccessful,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1272705:Unsuccessful [Qualitative Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "the possibility"

Phrase: "that"

Phrase: "the IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "detected in the 26S region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1552140:26s [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "caused by contamination"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0259846:contamination [Human-caused Phenomenon or Process]
   790   C1881659:CONTAMINATION [Event]
   790   C2349974:Contamination [Idea or Concept]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "by 20S-associated IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cannot"

Phrase: "be"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.189: Nevertheless, the copurification of IDE through several steps, including the 100,000 x g pelleting step, suggests that IDE may be associated with the 26S, as well as the 20S proteasome forms. 

Phrase: "Nevertheless,"

Phrase: "the copurification of IDE"

Phrase: "through several steps,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the 100,000 x g pelleting step,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1261552:Step [Conceptual Entity]
   799   C1704379:Step [Functional Concept]
   799   C1705117:Step [Quantitative Concept]
   799   C2825408:Step [Manufactured Object]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "associated with the 26S,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1552140:26s [Body Part, Organ, or Organ Component]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as well as"

Phrase: "the 20S proteasome forms."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]
   734   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1166808:20S proteasome [Cell Component]
Processing 00000000.tx.190: On the other hand, glycerol gradients using the 100,000 x g supernatant, presumably free of 26S proteasome, showed only migration of free IDE in a region that did not correspond to either the 20S or 26S proteasome (Fig. 6). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "glycerol gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0812409:gradients [Quantitative Concept]
   827 E C0439182:% gradient [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 100,000 x g supernatant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1550101:Supernatant [Body Substance]

Phrase: "presumably free of 26S proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "only migration of free IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0600210:Migration [Social Behavior]
   748   C1533574:Migration [Physiologic Function]
   748   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "in a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correspond to either"

Phrase: "the 20S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552134:20s [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.191: These data suggest that IDE can exist in at least two separate populations, one associated with proteasomes, and another free form, with an altered conformation that results in a different sedimentation pattern on glycerol density gradients. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "exist in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2987476:Exist [Conceptual Entity]

Phrase: "at least two separate populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "associated with proteasomes,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1325620:proteasome [Cell Component]
   756 E C1706221:Associate [Professional or Occupational Group]
   756 E C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "another free form,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0332296:free [Functional Concept]
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]

Phrase: "with an altered conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "that results in a different sedimentation pattern"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "on glycerol density gradients."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0178587:density [Quantitative Concept]
   827   C0812409:gradients [Quantitative Concept]
   793 E C0439182:% gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.192: This finding may explain the widely disparate reports of characteristics of IDE, including molecular size and catalytic properties (24, 44). 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "may"

Phrase: "explain"

Phrase: "the widely disparate reports of characteristics of IDE,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0684224:Reports [Intellectual Product]
   739   C0700287:reports [Health Care Activity]
   706 E C3273238:Report [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "molecular size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596969:molecular size [Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "catalytic properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "(24,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.193: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.194: Continuation of Table 1  If insulin inhibition is mediated by IDE, then insulin treatment might alter IDE and, as a result, its sedimentation on glycerol density gradients. 

Phrase: "Continuation of Table 1"

Phrase: "If"

Phrase: "insulin inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "mediated by IDE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "then insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "might"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: ","

Phrase: "as"

Phrase: "a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "its sedimentation on glycerol density gradients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0597428:Sedimentation [Laboratory Procedure]
   753   C1384604:Sedimentation [Natural Phenomenon or Process]
Processing 00000000.tx.195: Indeed, insulin treatment (Fig. 8) resulted in displacement of IDE from the proteasome-associated regions to the sedimentation area of free IDE. 

Phrase: "Indeed,"

Phrase: "insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "resulted in displacement of IDE"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   748   C0012725:Displacement [Mental Process]
   748   C0012727:Displacement [Spatial Concept]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0456080:Displacement [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2347509:Displacement [Phenomenon or Process]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "from the proteasome-associated regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "to the sedimentation area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "of free IDE."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   861   C0523720:free insulin [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.196: These data suggest a shift in IDE conformation after treatment with insulin, resulting in dissociation of IDE from the proteasome, and the data imply a greater activity of the proteasome when associated with IDE. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a shift in IDE conformation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resulting in dissociation of IDE"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   778   C0332294:Resulting in [Functional Concept]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   748   C0678226:resulting [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "from the proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "imply"

Phrase: "a greater activity of the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1622946:proteasome activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "when"

Phrase: "associated with IDE."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.197: This notion is supported by our previous data, which showed a reduction in proteasome activity when it was separated from IDE by chromatography, and an elevation when they were recombined (17). 

Phrase: "This notion"

Phrase: "is"

Phrase: "supported by our previous data,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205156:Previous [Temporal Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1521721:Supported [Conceptual Entity]
   760   C1552607:previous [Temporal Concept]
   760   C3245479:data [Medical Device]
   726 E C0183683:Support [Medical Device]

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a reduction in proteasome activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2267000:Reduction Activity [Molecular Function]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "it"

Phrase: "was"

Phrase: "separated from IDE"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by chromatography,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008550:Chromatography [Laboratory Procedure]
   900 E C0302647:chromatograph [Medical Device]

Phrase: "and"

Phrase: "an elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439775:Elevation [Therapeutic or Preventive Procedure]
  1000   C0702240:Elevation [Spatial Concept]

Phrase: "when"

Phrase: "they"

Phrase: "were"

Phrase: "recombined"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.198: The displacement of IDE from the proteasome provides a means by which insulin may regulate the activity of the 26S and 20S proteasomes. 

Phrase: "The displacement of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012725:Displacement [Mental Process]
   753   C0012727:Displacement [Spatial Concept]
   753   C0456080:Displacement [Qualitative Concept]
   753   C2347509:Displacement [Phenomenon or Process]

Phrase: "from the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a means by which insulin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "may"

Phrase: "regulate"

Phrase: "the activity of the 26S"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "20S proteasomes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           proteasomes
   983   C1166808:20S proteasome [Cell Component]
   827 E C1325620:proteasome [Cell Component]
   827 E C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.199: Insulin treatment of the complex results in removal of a proteasome regulatory protein, IDE. 

Phrase: "Insulin treatment of the complex results"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "in removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of a proteasome regulatory protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]

Phrase: "IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.200: Because previous studies (21) showed inhibition of non-ATP-dependent proteasome activity by other high-affinity IDE substrates (e.g. IGF-II), whereas lower-affinity substrates (e.g. IGF-I) had little or no effect, experiments are currently underway to determine whether these other IDE substrates have effects on ATP-dependent degradation and IDE-proteasome association, or if these effects are specific for insulin. 

Phrase: "Because"

Phrase: "previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(21"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "inhibition of non-ATP-dependent proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by other high-affinity IDE substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   810   C0178623:enzyme substrate [Chemical Viewed Functionally]
   766   C1710236:Substrate [Manufactured Object]

Phrase: "("

Phrase: "e.g. IGF-II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "lower-affinity substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "("

Phrase: "e.g. IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "had"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "currently underway to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521116:Currently [Temporal Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "these other IDE substrates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0178623:enzyme substrate [Chemical Viewed Functionally]
   779   C1710236:Substrate [Manufactured Object]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "have"

Phrase: "effects on ATP-dependent degradation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "IDE-proteasome association,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0004083:Association [Mental Process]
   804   C0439849:Association [Qualitative Concept]
   804   C0596306:Association [Phenomenon or Process]
   804   C0699792:association [Social Behavior]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "or"

Phrase: "if"

Phrase: "these effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "specific for insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]
Processing 00000000.tx.201: Last, though the possibility remains that one or more fragments of insulin act to indirectly inhibit the proteasome, previous studies suggested that insulin fragments generated by IDE have little effect on proteasome activity (21). 

Phrase: "Last,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517741:Last [Qualitative Concept]

Phrase: "though"

Phrase: "the possibility"

Phrase: "remains"

Phrase: "that one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "fragments of insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1708096:Fragment [Qualitative Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to indirectly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "generated by IDE"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3146294:Generated [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "have"

Phrase: "little effect on proteasome activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.202: Because IDE copurified with the proteasome through the 100,000 x g precipitation step and was detected in the 26S region and the 20S region on glycerol gradients, these data are the first to suggest that IDE may be associated with both the 26S and 20S proteasomes. 

Phrase: "Because"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "copurified with the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "through the 100,000 x g precipitation step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1261552:Step [Conceptual Entity]
   799   C1704379:Step [Functional Concept]
   799   C1705117:Step [Quantitative Concept]
   799   C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "was"

Phrase: "detected in the 26S region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1552140:26s [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the 20S region on glycerol gradients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "associated with both"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "the 26S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552140:26s [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "20S proteasomes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           proteasomes
   983   C1166808:20S proteasome [Cell Component]
   827 E C1325620:proteasome [Cell Component]
   827 E C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.203: Because the 20S catalytic core is a common element of both forms of the proteasome, it seems likely that IDE associates with this catalytic core as an accessory or regulatory protein, which would provide a mechanism by which insulin inhibits both ATP-dependent and ATP-independent proteasome activity. 

Phrase: "Because"

Phrase: "the 20S catalytic core"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0600499:Catalytic Core [Amino Acid Sequence]
   827   C0444669:Core [Spatial Concept]
   827   C1167518:core [Cell Component]
   827   C1706352:Core [Medical Device]
   827   C1882467:Core [Manufactured Object]
   827   C3274653:Core [Body Substance]

Phrase: "is"

Phrase: "a common element of both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0013879:Element [Element, Ion, or Isotope]
   760   C1705248:Element [Conceptual Entity]

Phrase: "forms of the proteasome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1325620:proteasome [Cell Component]
   770   C1522492:Form [Functional Concept]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "it"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "associates with this catalytic core"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0600499:Catalytic Core [Amino Acid Sequence]
   760   C0007382:Catalytic [Natural Phenomenon or Process]
   760   C0444669:Core [Spatial Concept]
   760   C0750490:Associate [Idea or Concept]
   760   C1167518:core [Cell Component]
   760   C1706221:Associate [Professional or Occupational Group]
   760   C1706352:Core [Medical Device]
   760   C1882467:Core [Manufactured Object]
   760   C3274653:Core [Body Substance]

Phrase: "as an accessory"

Phrase: "or"

Phrase: "regulatory protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]

Phrase: "which"

Phrase: "would"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a mechanism by which insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "both ATP-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "ATP-independent proteasome activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1622946:proteasome activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.204: The presence of IDE with the proteasome is accompanied by an elevated level of activity, possibly through an allosteric effect on the proteasome. 

Phrase: "The presence of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "with the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "accompanied by an elevated level of activity,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C0683317:Activity level [Finding]
   748   C0205177:Activity [Functional Concept]
   748   C0205250:Elevated [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C1561536:*Activity [Idea or Concept]
   748   C2946261:Level [Pharmacologic Substance]
   748   C3163633:Elevated [Qualitative Concept]

Phrase: "possibly through an allosteric effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
   760   C2362652:Possibly [Qualitative Concept]

Phrase: "on the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.205: Insulin treatment results in IDE dissociation from the proteasome and a reduction in proteasome activity. 

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "results in IDE dissociation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   753   C1274040:Result [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1546471:Result [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2825142:Result [Finding]

Phrase: "from the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "a reduction in proteasome activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2267000:Reduction Activity [Molecular Function]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.206: This mechanism would be consistent with the effects seen with in vitro extracts and in cultured cell experiments. 

Phrase: "This mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "would"

Phrase: "be"

Phrase: "consistent with the effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "seen with in vitro extracts"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
   726   C2828366:Extract [Substance]

Phrase: "and in cultured cell experiments."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0007635:cultured cell [Cell]
   790 E C0007585:culture cell [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0681814:Experiments [Research Activity]
   760   C1269647:Cell [Cell]
   760   C1515981:And [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C1706386:Experiment [Conceptual Entity]
   726   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.207: Furthermore, this mechanism supports earlier results suggesting that IDE was responsible for mediating insulin regulation of the proteasome (17, 19, 20, 21). 

Phrase: "Furthermore,"

Phrase: "this mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "earlier results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "responsible for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1273518:Responsible [Finding]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "insulin regulation of the proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "(17,"

Phrase: "19,"

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.208: There are a number of possible reasons why other studies have not detected the presence of IDE in proteasome preparations. 

Phrase: "There"

Phrase: "are"

Phrase: "a number of possible reasons why"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the presence of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in proteasome preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.209: Many of the routine proteasome purification strategies use EDTA in the buffers. 

Phrase: "Many of the routine proteasome purification strategies"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0205547:Routine [Qualitative Concept]
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243114:purification [Functional Concept]
   748   C0439064:Many [Quantitative Concept]
   748   C0679199:strategies [Mental Process]
   748   C0747726:many [Conceptual Entity]
   748   C1325620:proteasome [Cell Component]
   748   C1752727:Proteasome [Molecular Function]
   748   C1998793:Purification [Functional Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "EDTA in the buffers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.210: Because IDE is a metalloproteinase, EDTA treatment causes inhibition of the insulin-degrading activity of IDE. 

Phrase: "Because"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a metalloproteinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "EDTA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "inhibition of the insulin-degrading activity of IDE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C2248397:inhibition of enzyme activity [Organism Function]
   757   C0877008:enzyme inhibition [Disease or Syndrome]
   757   C1524081:Enzyme Inhibition [Physiologic Function]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]
Processing 00000000.tx.211: Furthermore, EDTA treatment results in a reduction in the ability of IDE to associate with the proteasome (20). 

Phrase: "Furthermore,"

Phrase: "EDTA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "results in a reduction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in the ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085732:Ability [Organism Attribute]
   928 E C1299581:Able [Finding]

Phrase: "of IDE to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "associate with the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0750490:Associate [Idea or Concept]
   770   C1325620:proteasome [Cell Component]
   770   C1706221:Associate [Professional or Occupational Group]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.212: In addition, the use of anion exchange as a late step in the purification procedure can itself result in dissociation of the proteasome from IDE (16, 17). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the use of anion exchange"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "as a late step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "the purification procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "can"

Phrase: "itself"

Phrase: "result in dissociation of the proteasome"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1274040:Result [Functional Concept]
   753   C1325620:proteasome [Cell Component]
   753   C1546471:Result [Idea or Concept]
   753   C1752727:Proteasome [Molecular Function]
   753   C2825142:Result [Finding]

Phrase: "from IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.213: Finally, as shown in the present studies, the level of insulin degradation in the 26S region of the glycerol gradients is low, compared with that in the 20S and free regions, possibly because of inhibition of IDE by ATP (45). 

Phrase: "Finally,"

Phrase: "as"

Phrase: "shown in the present studies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726   C1547282:Show [Intellectual Product]
   726 E C2603343:Study [Research Activity]

Phrase: "the level of insulin degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0202098:Insulin level [Laboratory Procedure]
   797   C0428405:insulin level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the 26S region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the glycerol gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0812409:gradients [Quantitative Concept]
   827 E C0439182:% gradient [Quantitative Concept]

Phrase: "is"

Phrase: "low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the 20S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552134:20s [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "free regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "possibly because of inhibition of IDE"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   767   C0877008:enzyme inhibition [Disease or Syndrome]
   767   C1524081:Enzyme Inhibition [Physiologic Function]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C2362652:Possibly [Qualitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "by ATP"

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.214: Although the regulation of protein turnover by insulin has long been established, the proteolytic pathways involved have been unclear. 

Phrase: "Although"

Phrase: "the regulation of protein turnover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "the proteolytic pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "unclear."
Processing 00000000.tx.215: Our results provide the first demonstration that insulin inhibits ATP- and ubiquitin-dependent degradation by the proteasome in vitro and in cultured cells. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first demonstration"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ATP-"

Phrase: "and"

Phrase: "ubiquitin-dependent degradation by the proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and in cultured cells."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C1515981:And [Idea or Concept]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.216: These findings extend the cellular processes controlled by insulin to include the ubiquitin-proteasome pathway, a major cellular degradation system. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the cellular processes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0007613:Cellular Process [Cell Function]
   983   C1325880:cellular process [Cell Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "controlled by insulin to"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0332298:Controlled by [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the ubiquitin-proteasome pathway,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   976   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   901   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   865 E C1523807:proteasomal pathway [Molecular Function]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "a major cellular degradation system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.217: Because of the growing awareness of the importance of the ubiquitin pathway in the control of cellular processes, these data provide new understanding into the processes involved in a major action of insulin, the control of protein levels by regulation of proteolysis.  

Phrase: "Because of the growing awareness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004448:Awareness [Mental Process]

Phrase: "of the importance"

Phrase: "of the ubiquitin pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "in the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of cellular processes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0007613:Cellular Process [Cell Function]
   983   C1325880:cellular process [Cell Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "new understanding into the processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162340:Understanding [Mental Process]

Phrase: "involved in a major action of insulin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205164:Major [Qualitative Concept]
   748   C0441472:Action [Functional Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3266814:Action [Activity]

Phrase: "the control of protein levels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "by regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of proteolysis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]
Processing 00000000.tx.218: Footnotes  1 This work was funded, in part, by the Department of Veterans Affairs Research Service and, in part, by the Bly Memorial Research Fund, University of Nebraska Medical Center. 

Phrase: "Footnotes  1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "funded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016820:funded [Quantitative Concept]

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by the Department of Veterans Affairs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   861   C1549054:Veterans Affairs [Organization]
   812   C0042610:Veterans [Population Group]
   812   C1704729:Department [Organization]
   779 E C3245459:veteran [Intellectual Product]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Service"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557854:Service [Occupational Activity]
  1000   C2825316:Service [Manufactured Object]
  1000   C3245478:service [Idea or Concept]

Phrase: "and"

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by the Bly Memorial Research Fund,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681805:research fund [Research Activity]
   812   C0016820:Fund [Quantitative Concept]

Phrase: "University of Nebraska Medical Center."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
Processing 00000000.tx.219: 2 Current address: Section of Metabolism and Endocrinology, Carl T. 

Phrase: "2 Current address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0376649:Address [Intellectual Product]
   827   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Section of Metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205155:Section [Spatial Concept]
   790   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   790   C1522472:Section [Substance]
   790   C1552923:Section [Quantitative Concept]
   790   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "Endocrinology,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   928 E C0694557:endocrinologic [Functional Concept]

Phrase: "Carl T."
Processing 00000000.tx.220: Hayden Veterans Affairs Medical Center, 650 East Indian School Road, Phoenix, Arizona 85012. 

Phrase: "Hayden Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1549054:Veterans Affairs [Organization]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0042610:Veterans [Population Group]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
   771 E C3245459:veteran [Intellectual Product]

Phrase: "650 East Indian School Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0442650:Road [Manufactured Object]

Phrase: "Phoenix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331993:Phoenix [Health Care Related Organization]
  1000   C1080696:Phoenix [Plant]

Phrase: "Arizona 85012."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003787:Arizona [Geographic Area]
Processing 00000000.tx.221: Received August 27, 1999.  

Phrase: "Received August 27,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1999."
Processing 00000000.tx.222: References Top Abstract Introduction Materials and Methods Results Discussion References  Russell-Jones DL, Umpleby M 1996 Protein anabolic action of insulin, growth hormone and insulin-like growth factor-I. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Russell-Jones DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642216:/dL [Quantitative Concept]

Phrase: "Umpleby M 1996 Protein anabolic action of insulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441472:Action [Functional Concept]
   744   C3266814:Action [Activity]

Phrase: "growth hormone"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0037663:Growth Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0169964:Growth hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0019932:Hormone [Hormone]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "insulin-like growth factor-I."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.223: Eur J Endocrinol 135:631642[Medline] Mortimore GE, Mondon CE 1970 Inhibition by insulin of valine turnover in liver. 

Phrase: "Eur J Endocrinol 135"

Phrase: ":"

Phrase: "631642"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mortimore GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "Mondon CE 1970 Inhibition by insulin of valine turnover"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "in liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.224: J Biol Chem 245:23752383[Abstract/Free FullText] Fryberg DA, Jahn LA, Hill SA, Oliveras DM, Barrett EJ 1995 Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. 

Phrase: "J Biol Chem 245"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "23752383"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fryberg DA,"

Phrase: "Jahn LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Hill SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Oliveras DM,"

Phrase: "Barrett EJ 1995 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin-like growth factor-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "human skeletal muscle protein anabolism during hyperaminoacidemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0597295:protein anabolism [Molecular Function]
   748   C0005572:anabolism [Functional Concept]
   748   C0220781:Anabolism [Biologic Function]

Phrase: "by different mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.225: J Clin Invest 96:17221729[Medline] Ballard FJ, Wong SSC, Knowles SE, Partridge NC, Martin TJ, Wood CM, Gunn JM 1980 Insulin inhibition of protein degradation in cell monolayers. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "96"

Phrase: ":"

Phrase: "17221729"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ballard FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Wong SSC,"

Phrase: "Knowles SE,"

Phrase: "Partridge NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027964:NC [Geographic Area]
   861   C0028407:NC [Geographic Area]
   861   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Martin TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Wood CM,"

Phrase: "Gunn JM 1980 Insulin inhibition of protein degradation in cell monolayers."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   772   C1514541:Protein Degradation Inhibition [Physiologic Function]
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C3463820:Inhibition [Activity]
Processing 00000000.tx.226: J Cell Physiol 105:335346[Medline] Fulks RM, Li JB, Goldberg AL 1975 Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. 

Phrase: "J Cell Physiol 105"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "335346"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fulks RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Li JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Goldberg AL 1975 Effects of insulin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "amino acids on protein turnover"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   835   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "in rat diaphragm."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C1882640:Rat Diaphragm [Body Part, Organ, or Organ Component]
   861   C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   861   C0042241:DIAPHRAGM [Medical Device]
   861   C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   861   C1705367:Diaphragm [Medical Device]
   777 E C0229992:Mind, NOS [Mental Process]
   761 E C0229993:Psychic [Functional Concept]
   742 E C0086045:mindfulness [Mental Process]
   742 E C3542996:Mindfulness [Mental Process]
Processing 00000000.tx.227: J Biol Chem 250:290298[Abstract] Barrett EJ, Jahn LA, Oliveras DM, Fryberg DA 1995 Chloroquine does not exert insulin-like actions on human forearm muscle metabolism. 

Phrase: "J Biol Chem 250"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "290298"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Barrett EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Jahn LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Oliveras DM,"

Phrase: "Fryberg DA 1995 Chloroquine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   756 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "insulin-like actions on human forearm muscle metabolism."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0920875:actions muscle [Organ or Tissue Function]
   744   C0441472:actions [Functional Concept]
   711 E C3266814:Action [Activity]
Processing 00000000.tx.228: Am J Physiol 268:E820E824 Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL 1994 Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. 

Phrase: "Am"

Phrase: "J Physiol 268"

Phrase: ":"

Phrase: "E820E824 Rock KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1366480:KL [Gene or Genome]
   827   C1416656:KL [Gene or Genome]

Phrase: "Gramm C,"

Phrase: "Rothstein L,"

Phrase: "Clark K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Stein R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dick L,"

Phrase: "Hwang D,"

Phrase: "Goldberg AL 1994 Inhibitors of the proteasome"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   774   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   774   C2266856:Proteasome Inhibitors [Molecular Function]
   757 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the degradation of most cell proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "the generation of peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "presented on MHC class I molecules."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   866   C0019629:MHC Class I Molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C0017355:MHC Class I [Gene or Genome]
   790   C0441885:Class I [Classification]
   790   C2698967:Class I [Finding]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0449450:Presented [Idea or Concept]
   753   C0456387:Class [Intellectual Product]
   753   C0567416:molecules [Substance]
   753   C1705943:Class [Classification]
   719 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.229: Cell 78:761771[Medline] Coux O, Tanaka K, Goldberg AL 1996 Structure and functions of the 20S and 26S proteasomes. 

Phrase: "Cell 78"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "761771"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Coux O,"

Phrase: "Tanaka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Goldberg AL 1996 Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "functions of the 20S"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1552134:20s [Body Part, Organ, or Organ Component]
   770   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "26S proteasomes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   983   C1166804:26S proteasome [Cell Component]
   861   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C1325620:proteasome [Cell Component]
   827 E C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.230: Annu Rev Biochem 65:801847[CrossRef][Medline] Rivett AJ, Savory PJ, Djaballah H 1994 Multicatalytic endopeptidase complex: Proteasome. 

Phrase: "Annu Rev Biochem 65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450385:65 [Intellectual Product]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "801847"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rivett AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Savory PJ,"

Phrase: "Djaballah H 1994 Multicatalytic endopeptidase complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0208355:multicatalytic endopeptidase complex [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]

Phrase: ":"

Phrase: "Proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.231: Methods Enzymol 244:331351[Medline] Hershko A, Ciechanover A 1998 The ubiquitin system. 

Phrase: "Methods Enzymol 244"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "331351"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hershko A,"

Phrase: "Ciechanover"

Phrase: "A 1998"

Phrase: "The ubiquitin system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.232: Annu Rev Biochem 67:425479[CrossRef][Medline] Hochstrasser M 1995 Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. 

Phrase: "Annu Rev Biochem 67"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "425479"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hochstrasser M 1995 Ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "proteasomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1325620:proteasome [Cell Component]
   966 E C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "the regulation of intracellular protein degradation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1158003:regulation of protein degradation [Cell Function]
   820   C1158158:regulation of degradation [Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.233: Curr Opin Cell Biol 7:215223[CrossRef][Medline] Wilkinson KD, Urban MK, Haas AL 1980 Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. 

Phrase: "Curr Opin Cell Biol 7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "215223"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wilkinson KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Urban MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Haas AL 1980 Ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the ATP-dependent proteolysis factor I of rabbit reticulocytes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0021966:I- [Inorganic Chemical]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.234: J Biol Chem 255:75297532[Abstract/Free FullText] Hasselgren P, Fischer JE 1997 The ubiquitin-proteasome pathway. 

Phrase: "J Biol Chem 255"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "75297532"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hasselgren P,"

Phrase: "Fischer JE 1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0454673:JE [Geographic Area]
   827   C1550752:JE [Temporal Concept]

Phrase: "The ubiquitin-proteasome pathway."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   976   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   901   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   865 E C1523807:proteasomal pathway [Molecular Function]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.235: Ann Surg 225:307316[CrossRef][Medline] Wilkinson KD 1995 Roles of ubiquitinylation in proteolysis and cellular regulation. 

Phrase: "Ann Surg 225"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3541227:Surg [Temporal Concept]

Phrase: ":"

Phrase: "307316"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wilkinson KD 1995 Roles of ubiquitinylation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "in proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "cellular regulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596286:Cellular Regulation [Cell Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.236: Annu Rev Nutr 15:161189[CrossRef][Medline] Pepato MT, Migliorini RH, Goldberg AL, Kettelhut IC 1996 Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats. 

Phrase: "Annu Rev Nutr 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "161189"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pepato MT,"

Phrase: "Migliorini RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Goldberg AL,"

Phrase: "Kettelhut IC 1996 Role of different proteolytic pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "of muscle protein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0026845:Muscle [Tissue]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "from streptozotocin-diabetic rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.237: Am J Physiol 271:E340E347 Bennett RG, Hamel FG, Duckworth WC 1994 Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase. 

Phrase: "Am"

Phrase: "J Physiol 271"

Phrase: ":"

Phrase: "E340E347 Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 1994 Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020792:Identification [Mental Process]
   812   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "isolation of a cytosolic proteolytic complex containing insulin degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0204727:Isolation [Therapeutic or Preventive Procedure]
   739   C0205409:Isolation [Functional Concept]
   739   C0220862:isolation [Laboratory Procedure]

Phrase: "and"

Phrase: "the multicatalytic proteinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.238: Biochem Biophys Res Commun 202:10471053[CrossRef][Medline] Duckworth WC, Bennett RG, Hamel FG 1994 A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin degrading enzyme and multicatalytic proteinase. 

Phrase: "Biochem Biophys Res Commun 202"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "10471053"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1994"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439214:fg [Quantitative Concept]
   827   C2348814:FG [Quantitative Concept]

Phrase: "A direct inhibitory effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on a cytosolic proteolytic complex containing insulin degrading enzyme"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   877   C0030940:Proteolytic enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   877   C1947941:Proteolytic Enzyme [Enzyme]
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "multicatalytic proteinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.239: J Biol Chem 269:2457524580[Abstract/Free FullText] Hamel FG, Bennett RG, Harmon KS, Duckworth WC 1997 Insulin inhibition of proteasome activity in intact cells. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2457524580"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Harmon KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Duckworth WC 1997 Insulin inhibition of proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in intact cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.240: Biochem Biophys Res Commun 234:671674[CrossRef][Medline] Duckworth WC, Bennett RG, Hamel FG 1998 Insulin acts intracellularly on proteasomes through insulin-degrading enzyme. 

Phrase: "Biochem Biophys Res Commun 234"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "671674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1998 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "intracellularly on proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C1325620:proteasome [Cell Component]
   756 E C1752727:Proteasome [Molecular Function]

Phrase: "through insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.241: Biochem Biophys Res Commun 244:390394[CrossRef][Medline] Hamel FG, Bennett RG, Duckworth WC 1998 Regulation of the multicatalytic enzyme activity by insulin and the insulin degrading enzyme. 

Phrase: "Biochem Biophys Res Commun 244"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "390394"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Duckworth WC 1998 Regulation of the multicatalytic enzyme activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   807   C1327623:regulation of enzyme activity [Molecular Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the insulin degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.242: Endocrinology 139:40614066[Abstract/Free FullText] Bennett RG, Hamel FG, Duckworth WC 1997 Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex. 

Phrase: "Endocrinology 139"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "40614066"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 1997 Characterization of the insulin inhibition of the peptidolytic activities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1880022:Characterization [Activity]

Phrase: "of the insulin-degrading enzyme-proteasome complex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
Processing 00000000.tx.243: Diabetes 46:197203[Abstract] Hough R, Rechsteiner M 1986 Ubiquitin-lysozyme conjugates. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "197203"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hough R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rechsteiner M 1986 Ubiquitin-lysozyme conjugates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0301869:conjugates [Immunologic Factor]
Processing 00000000.tx.244: J Biol Chem 261:23912399[Abstract/Free FullText] Duckworth WC, Bennett RG, Hamel FG 1998 Insulin degradation: progress and potential. 

Phrase: "J Biol Chem 261"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "23912399"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1998 Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C3547574:insulin degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.245: Endocr Rev 19:608624[Abstract/Free FullText] Becker AB, Roth RA 1995 Insulysin and pitrilysin: insulin-degrading enzymes of mammals and bacteria. 

Phrase: "Endocr Rev 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "608624"

Phrase: "[Abstract/Free FullText"

Phrase: "] Becker AB,"

Phrase: "Roth RA 1995 Insulysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1415875:INSULYSIN [Gene or Genome]

Phrase: "and"

Phrase: "pitrilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0208233:pitrilysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "insulin-degrading enzymes of mammals"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   828   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   828   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "bacteria."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004611:Bacteria [Bacterium]
  1000   C1510439:bacteria [Functional Concept]
  1000   C2347473:% Bacteria [Quantitative Concept]
   928 E C0521009:Bacterial [Qualitative Concept]
Processing 00000000.tx.246: Methods Enzymol 248:693703[Medline] Shii K, Roth RA 1986 Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. 

Phrase: "Methods Enzymol 248"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "693703"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shii K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roth RA 1986 Inhibition of insulin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0677626:hepatoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "after microinjection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025991:Microinjection [Therapeutic or Preventive Procedure]

Phrase: "of monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to a specific cytosolic protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
Processing 00000000.tx.247: Proc Natl Acad Sci USA 83:41474151[Abstract] Shibatani T, Ward WF 1995 Sodium dodecyl sulfate (SDS) activation of the 20S proteasome in rat liver. 

Phrase: "Proc Natl Acad Sci USA 83"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "41474151"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shibatani T,"

Phrase: "Ward WF 1995 Sodium dodecyl sulfate (SDS) activation of the 20S proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1879547:Activation [Activity]

Phrase: "in rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.248: Arch Biochem Biophys 321:160166[CrossRef][Medline] Ciechanover A, Hod Y, Hershko A 1978 A heat-stable component of an ATP-dependent proteolytic system from reticulocytes. 

Phrase: "Arch Biochem Biophys 321"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0230467:arch [Body Location or Region]
   812   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "160166"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ciechanover A,"

Phrase: "Hod Y,"

Phrase: "Hershko"

Phrase: "A 1978"

Phrase: "A heat-stable component of an ATP-dependent proteolytic system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0449432:Component [Manufactured Object]
   739   C1705248:Component [Conceptual Entity]

Phrase: "from reticulocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035286:Reticulocytes [Cell]
Processing 00000000.tx.249: Biochem Biophys Res Commun 81:11001105[Medline] Parker CW 1990 Radiolabeling of proteins. 

Phrase: "Biochem Biophys Res Commun 81"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "11001105"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Parker CW 1990 Radiolabeling of proteins."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C2347885:Radiolabeling [Laboratory Procedure]
   719 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.250: In: Deutscher MP (ed) Guide to Protein Purification. 

Phrase: "In"

Phrase: ":"

Phrase: "Deutscher MP (ed)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538926:ED [Idea or Concept]

Phrase: "Guide to Protein Purification."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0597301:protein purification [Laboratory Procedure]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0181090:Guide [Professional or Occupational Group]
   770   C0243114:purification [Functional Concept]
   770   C0302614:Guide [Medical Device]
   770   C1706050:Guide [Manufactured Object]
   770   C1998793:Purification [Functional Concept]
Processing 00000000.tx.251: Academic Press, San Diego, vol 182:721737 Hough R, Pratt G, Rechsteiner M 1987 Purification of two high molecular weight proteases from rabbit reticulocyte lysate. 

Phrase: "Academic Press,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "vol 182"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]

Phrase: ":"

Phrase: "721737 Hough R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Pratt G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rechsteiner M 1987 Purification of two high molecular weight proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0243114:purification [Functional Concept]
   739   C1998793:Purification [Functional Concept]

Phrase: "from rabbit reticulocyte lysate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034493:Rabbit [Mammal]
   827   C0035286:Reticulocyte [Cell]
   827   C1881488:Lysate [Physical Object]
Processing 00000000.tx.252: J Biol Chem 262:83038313[Abstract/Free FullText] Born LJ, Kharbanda KK, McVicker DL, Zetterman RK, Donohue TM 1996 Effects of ethanol administration on components of the ubiquitin proteolytic pathway in rat liver. 

Phrase: "J Biol Chem 262"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "83038313"

Phrase: "[Abstract/Free FullText"

Phrase: "] Born LJ,"

Phrase: "Kharbanda KK,"

Phrase: "McVicker DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Zetterman RK,"

Phrase: "Donohue TM 1996 Effects of ethanol administration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "of the ubiquitin proteolytic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "in rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.253: Hepatology 23:15561563[Medline] Sawada H, Muto K, Fujimuro M, Akashi T, Sawada MT, Yokosawa H, Goldberg AL 1993 Different ratios of 20 S proteasomes and regulatory subunit complexes in two isoforms of the 26 S proteasome purified from rabbit skeletal muscle. 

Phrase: "Hepatology 23"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086403:Hepatology [Biomedical Occupation or Discipline]
   861   C0450348:23 [Quantitative Concept]
   861   C1555763:Hepatology [Professional or Occupational Group]

Phrase: ":"

Phrase: "15561563"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sawada H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Muto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fujimuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Akashi T,"

Phrase: "Sawada MT,"

Phrase: "Yokosawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Goldberg AL 1993 Different ratios of 20 S proteasomes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0456603:Ratios [Quantitative Concept]
   742   C1610540:*Ratios [Quantitative Concept]
   708 E C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "regulatory subunit complexes in two isoforms of the 26 S proteasome"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C1704241:Complexes [Chemical Viewed Structurally]
   704 E C0439855:Complex [Qualitative Concept]

Phrase: "purified from rabbit skeletal muscle."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0242692:Muscle, Skeletal [Tissue]
   806   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   760   C0026845:Muscle [Tissue]
   760   C0034493:Rabbit [Mammal]
   760   C0037253:skeletal [Body System]
   760   C0521324:Skeletal [Spatial Concept]
   760   C1998793:Purified [Functional Concept]
Processing 00000000.tx.254: FEBS Lett 335:207212[CrossRef][Medline] Haas AL, Rose IA 1981 Hemin inhibits ATP-dependent ubiquitin-dependent proteolysis: role of hemin in regulating ubiquitin conjugate degradation. 

Phrase: "FEBS Lett 335"

Phrase: ":"

Phrase: "207212"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Haas AL,"

Phrase: "Rose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "IA 1981 Hemin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018988:Haemin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ATP-dependent ubiquitin-dependent proteolysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   911   C1157967:ATP-dependent proteolysis [Molecular Function]
   804   C0597304:Proteolysis [Molecular Function]
   733 E C1947941:proteolytic [Enzyme]

Phrase: ":"

Phrase: "role of hemin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "regulating"

Phrase: "ubiquitin conjugate degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]
Processing 00000000.tx.255: Proc Natl Acad Sci USA 78:68456848[Abstract] Dahl DC, Tsao T, Duckworth WC, Frank BH, Rabkin R 1990 Effect of bacitracin on retroendocytosis and degradation of insulin in cultured kidney epithelial cell line. 

Phrase: "Proc Natl Acad Sci USA 78"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "68456848"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dahl DC,"

Phrase: "Tsao T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0169255:TSAO-T [Organic Chemical,Pharmacologic Substance]

Phrase: "Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Frank BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Rabkin R 1990 Effect of bacitracin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on retroendocytosis"

Phrase: "and"

Phrase: "degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C3547574:insulin degradation [Molecular Function]
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "in cultured kidney epithelial cell line."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   911   C0007600:Cultured Cell Line [Cell]
           Cell Line
   875   C0007635:cultured cell [Cell]
   856   C0806036:Renal epithelial cell [Cell]
   853   C0553257:kidney cell [Cell]
   840   C0014597:Epithelial cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C0221908:Epithelial [Qualitative Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.256: Diabetes 39:13391346[Abstract] Mimnaugh EG, Bonvini P, Neckers L 1999 The measurement of ubiquitin and ubiquitinated proteins. 

Phrase: "Diabetes 39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "13391346"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mimnaugh EG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013715:EG [Geographic Area]
   861   C1705651:EG [Idea or Concept]

Phrase: "Bonvini P,"

Phrase: "Neckers L 1999"

Phrase: "The measurement of ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "and"

Phrase: "ubiquitinated proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1956096:Ubiquitinated Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.257: Electrophoresis 20:418428[CrossRef][Medline] Wing SS, Banville D 1994 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. 

Phrase: "Electrophoresis 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: ":"

Phrase: "418428"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wing SS,"

Phrase: "Banville D 1994 14-kDa ubiquitin-conjugating enzyme"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   835   C0084913:Ubiquitin-conjugating enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0014442:Enzyme [Enzyme,Organic Chemical]
   793   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0301869:Conjugate [Immunologic Factor]
   710 E C0014445:enzymes [Functional Concept]

Phrase: ":"

Phrase: "structure of the rat gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C1517495:Gene Structure [Gene or Genome]
   762 E C0017366:Structural gene [Gene or Genome]
   760   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "regulation upon fasting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "and by insulin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.258: Am J Physiol 267:E39E48 Larbaud D, Debras E, Taillandier D, Samuels SE, Temparis S, Champredon C, Grizard J, Attaix D 1996 Euglycemic hyperinsulinemia and hyperaminoacidemia decrease skeletal muscle ubiquitin mRNA in goats. 

Phrase: "Am"

Phrase: "J Physiol 267"

Phrase: ":"

Phrase: "E39E48 Larbaud D,"

Phrase: "Debras E,"

Phrase: "Taillandier D,"

Phrase: "Samuels SE,"

Phrase: "Temparis S,"

Phrase: "Champredon C,"

Phrase: "Grizard J,"

Phrase: "Attaix D 1996 Euglycemic hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "hyperaminoacidemia"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "skeletal muscle ubiquitin mRNA in goats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.259: Am J Physiol 271:E505E512 Price SR, Bailey JL, Wang X, Jurkovitz C, England BK, Ding X, Phillips LS, Mitch WE 1996 Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome pathway by a mechanism including gene transcription. 

Phrase: "Am"

Phrase: "J Physiol 271"

Phrase: ":"

Phrase: "E505E512 Price SR,"

Phrase: "Bailey JL,"

Phrase: "Wang X,"

Phrase: "Jurkovitz C,"

Phrase: "England BK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006100:BK [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1537501:BK [Gene or Genome]

Phrase: "Ding X,"

Phrase: "Phillips LS,"

Phrase: "Mitch"

Phrase: "WE 1996 Muscle wasting in insulinopenic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0026846:Muscle wasting [Disease or Syndrome]
   748   C0026845:Muscle [Tissue]
   748   C0235394:Wasting [Disease or Syndrome]

Phrase: "results from activation of the ATP-dependent, ubiquitin-proteasome pathway"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   760   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   758   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   739   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0851827:Dependent [Qualitative Concept]
   739   C1274040:Result [Functional Concept]
   739   C1325620:proteasome [Cell Component]
   739   C1546471:Result [Idea or Concept]
   739   C1701901:Dependent [Qualitative Concept]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
   739   C1879547:Activation [Activity]
   739   C2825142:Result [Finding]
   739   C3244310:dependent [Functional Concept]
   724 E C1523807:proteasomal pathway [Molecular Function]

Phrase: "by a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "gene transcription."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040649:Gene Transcription [Genetic Function]
           Transcription
Processing 00000000.tx.260: J Clin Invest 98:17031708[Abstract/Free FullText] Wing SS, Bedard N 1996 Insulin-like growth factor I stimulates degradation of an mRNA transcript encoding the 14 kDa ubiquitin-conjugating enzyme. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "98"

Phrase: ":"

Phrase: "17031708"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wing SS,"

Phrase: "Bedard N 1996 Insulin-like growth factor I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   890   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   890   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   822   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0021966:I- [Inorganic Chemical]
   793   C0220844:growth [Physiologic Function]
   793   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "degradation of an mRNA transcript"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1257759:mRNA Transcript Degradation [Genetic Function]
           mRNA Degradation
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the 14 kDa ubiquitin-conjugating enzyme."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C0084913:Ubiquitin-conjugating enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0301869:Conjugate [Immunologic Factor]
   721 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.261: Biochem J 319:455461[Medline] Mason GG, Hendil KB, Rivett AJ 1996 Phosphorylation of proteasomes in mammalian cells: identification of two phosphorylated subunits and the effect of phosphorylation on activity. 

Phrase: "Biochem J 319"

Phrase: ":"

Phrase: "455461"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mason GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018370:GG [Geographic Area]

Phrase: "Hendil KB,"

Phrase: "Rivett AJ 1996 Phosphorylation of proteasomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "in mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "identification of two phosphorylated subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "the effect of phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.262: Eur J Biochem 238:453462[Abstract] Castano JG, Mahillo E, Arizti P, Arribas J 1996 Phosphorylation of C8 and C9 subunits of the multicatalytic proteinase by casein kinase II and identification of the C8 phosphorylation sites by direct mutagenesis. 

Phrase: "Eur J Biochem 238"

Phrase: ":"

Phrase: "453462"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Castano JG,"

Phrase: "Mahillo E,"

Phrase: "Arizti P,"

Phrase: "Arribas J 1996 Phosphorylation of C8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "C9 subunits of the multicatalytic proteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1711351:Subunit [Quantitative Concept]

Phrase: "by casein kinase II"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0108555:Casein Kinase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "identification of the C8 phosphorylation sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "by direct mutagenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079866:Mutagenesis [Molecular Function]
   861   C3146302:Mutagenesis [Laboratory Procedure]
Processing 00000000.tx.263: Biochemistry 35:37823789[CrossRef][Medline] Pereira ME, Wilk S 1990 Phosphorylation of the multicatalytic proteinase complex from bovine pituitaries by a copurifying cAMP-dependent protein kinase. 

Phrase: "Biochemistry 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "37823789"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pereira"

Phrase: "ME,"

Phrase: "Wilk S 1990 Phosphorylation of the multicatalytic proteinase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "from bovine pituitaries"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]

Phrase: "by a copurifying cAMP-dependent protein kinase."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C0010531:cAMP-Dependent Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
Processing 00000000.tx.264: Arch Biochem Biophys 283:6874[Medline] DeMartino GN, Slaughter CA 1993 Regulatory proteins of the proteasome. 

Phrase: "Arch Biochem Biophys 283"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0230467:arch [Body Location or Region]
   812   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "6874"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] DeMartino GN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018381:GN [Geographic Area]

Phrase: "Slaughter CA 1993 Regulatory proteins of the proteasome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0220905:regulatory [Regulation or Law]
   744   C1704735:Regulatory [Conceptual Entity]
Processing 00000000.tx.265: Enzyme Protein 47:314324[Medline] Kanayama H, Tamura T, Ugai S, Kagawa S, Tanahashi N, Yoshimura T, Tanaka K, Ichihara A 1992 Demonstration that a human 26S proteolytic complex consists of a proteasome and multiple associated protein components and hydrolyzes ATP and ubiquitin-ligates proteins by closely linked mechanisms. 

Phrase: "Enzyme Protein 47"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ":"

Phrase: "314324"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kanayama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tamura T,"

Phrase: "Ugai S,"

Phrase: "Kagawa S,"

Phrase: "Tanahashi N,"

Phrase: "Yoshimura T,"

Phrase: "Tanaka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ichihara"

Phrase: "A 1992 Demonstration"

Phrase: "that"

Phrase: "a human 26S proteolytic complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "consists of a proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0332529:CONSIST [Qualitative Concept]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "multiple associated protein components"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C1179435:Protein Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0449432:Components [Manufactured Object]
   779 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "hydrolyzes"

Phrase: "ATP"

Phrase: "and"

Phrase: "ubiquitin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ligates"

Phrase: "proteins by closely linked mechanisms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.266: Eur J Biochem 206:567578[Abstract] Duckworth WC 1988 Insulin degradation: mechanisms, products, and significance. 

Phrase: "Eur J Biochem 206"

Phrase: ":"

Phrase: "567578"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Duckworth WC 1988 Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C3547574:insulin degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.267: Endocr Rev 9:319345[Abstract] Camberos M, Udrisar D, Perez A, Wanderley M, Cresto J 1998 "In vitro " binding of insulin-degrading enzyme (IDE) to ATP inhibits insulin degradation. Diabetes 47:A239 (Abstract)

Phrase: "Endocr Rev 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "319345"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Camberos M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Udrisar D,"

Phrase: "Perez A,"

Phrase: "Wanderley M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cresto J 1998 ""In vitro "" binding of insulin-degrading enzyme"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1149286:enzyme binding [Molecular Function]
   757   C1623517:insulin binding [Molecular Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "to ATP"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin degradation. Diabetes 47"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   861   C3547574:insulin degradation [Molecular Function]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "A239"

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")"

